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Abstract 
This review examines the contention that palliative care offers a restricted level of 
service to the community if it does not formally incorporate the psychological 
support of dying patients and their families in routine terminal care. The attributional 
model of responsibility for problems and solutions proposed by Brickman and 
colleagues (1982) is used to encapsulate the difference between a traditional medical 
role for patients compared with a more satisfactory psychological orientation, 
whereby the dynamic participation· of patients and families in the treatment of the 
final days of life is strengthened. Use of alternative therapies is suggested as one 
method by which this could be achieved. This review suggests that at the present 
time, in Tasmania and possibly further afield, the contribution to palliative care 
which psychologists are capable of making is insufficiently utilised. They are able to 
provide a much needed resource at a time when treatment of terminal illness is 
moving beyond physical care towards a more holistic approach to patient care in 
order to maximise the quality of the last stages of life. 
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Diseases are expressed in different ways in different people (Holmes, 1992). 
The outcome of any treatment of disease depends on more than just the curative 
power of the treatment; it depends on a range of physical and psychological variables 
pertaining to the patient (Cassell, 1991). This being the case, a multidisciplinary 
approach to disease, routinely involving a range of health care professionals, is likely 
to lead to the best overall outcomes (White, 1996), because each discipline will make 
its own unique contribution to the patient's ailment. That contribution refers to more 
than the specialist knowledge that, for example, psychology or physiotherapy can 
offer. It refers to the professional orientation of the practitioner and his or her 
fundamental treatment goals. Delineating the contributions of each of these 
profes~ions is beyond the scope of this paper, therefore the particular potential of 
psychological intervention in palliative care will provide an example of the benefits 
of holistic care. 
Psychology is uniquely suited to palliative care because, unlike acute medical 
care, the primary goals of psychological intervention emphasise quality of life rather 
than prolongation, and promote patient efficacy rather than acting for the patient (see 
for example, Bannerman, 1992). These goals are complementary to the aims of 
palliative care, specifically those aims directed at improving quality, autonomy and 
achieving a peaceful acceptance of death (Ipswich & West Moreton Division of 
General Practice (I&WMDGP), 1994). 
Psychological shifts in palliative care 
On the one hand, palliative care, as a discipline separate from mainstream 
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acute hospital care, is a comparatively recent phenomenon (White, 1996), with 
hospice programs, home care and specialist units developing in Australia mainly 
from the early 1980s. In Tasmania, it has largely been focussed on units based in 
acute care hospitals (Hodder & Turley, 1991). On the other hand, it can be argued 
that it is one of the oldest medical disciplines, given that palliation was often the only 
way to deal with many serious illnesses in the days before the complex, 
technologically sophisticated treatments now available for diseases such as cancer 
(Woodruff, 1993). These treatments emphasise the greater potential for a cure or 
remission, and perhaps result in greater attention to medical care for physical ills, 
somewhat to the detriment of psychological and/or palliative care (Cassell, 1991). 
In the simplest terms, palliative care refers to intervention at the stage of 
terminal illness in which the disease has progressed to the point where curative 
treatment is no longer likely to bring about positive results (World Health 
Organisation (WHO), 1990). The focus shifts, instead, to making a patient as 
comfortable as possible by treating the symptoms rather than the cause of the illness 
.(Dudgeon, et al., 1995). Actively attending to psychosocial problems is equally 
important, with the prevailing goal being the maximum quality of life for patients 
and their families (WHO, 1990). A patient must learn to relinquish hope of recovery 
and adjust to imminent mortality (Sarafino, 1990). In the best circumstances a 
patient is encouraged "to live until he (sic) dies, at his own maximum potential...with 
control and independence wherever possible" (Saunders, 1984, p.233). The family 
must also make this adjustment, in addition to preparing for further changes after a 
patient's death (Parkes, 1984). 
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Unfortunately, a traditional medical approach takes a reductionist perspective 
by placing greater weight on the biological aspects of a patient than on the 
psychological (Birch, 1993; Home, 1992). In fact, the actual physical disease is only 
a component of the whole experience of an illness (Zalcberg, 1992). Patients and 
carers often receive haphazard guidance in adjusting to terminal illness and death, 
depending upon the degree to which their distress is recognised and/or interferes with 
medical treatment. Specialist palliative care facilities and practitioners in the 
community have considerable experience in working with people who are facing 
death. A patient with a terminal illness must make the psychological shifts from 
'well person' to 'sick person' to 'dying person' and come to terms with all the 
disappointments inherent in this progression (Parkes, 1984). However, in Tasmania, 
there is no emphasis on and no formal structure to support these shifts, apart from 
information about the progression of the illness. This means that many patients lack 
help in making these very difficult transitions. In order to help patients best, 
physicians and carers must also make these shifts in terms of the way they interact 
with patients and the goals they are working towards. 
The ability to accommodate a given treatment regime is determined by the 
specified goal. If the goal is to eradicate the disease, patients will be more willing to 
' 
tolerate undesirable side effects for a finite period of time and less likely to interpreet 
symptoms as painful (Turk, 1996). If a cure is not feasible, then palliative care takes 
over from mainstream medical care and the goal of treatment must alter to focus on 
quality of life issues, for example, symptom control and family affairs. Side effects 
from both the disease and the treatment become less tolerable and attain greater 
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significance (Lowenthal, 1990). This emphasis on quality of life, while relinquishing 
the prospect of a cure, represents a departure from the usual medical goals. The 
training offered during undergraduate medical degrees is focussed upon the 
eradication of injury or disease, although in recent years a more patient-centred 
orientation has been introduced (University of Melbourne, 1995). 
Attribution of responsibility 
In the case of terminal cancer, patients must contend with an uncertain and 
curtailed lifespan, a restricted range of activity, and, in many cases, with pain that has 
no positive meaning and may not be entirely preventable, all of which severely 
reduce their quality of life (Bonica, 1992). The achievement of control over pain is 
_extremely important in easing physical and mental distress (Patt, 1992). Medication 
is the core of cancer pain control (Hodder & Turley, 1991) and is ideally supported 
by many other therapies, according to the needs and wishes of the patients and their 
families. Control of chronic benign pain requires a long term approach which 
cautions against overreliance on pharmacotherapy (Bonica, 1992; Kinney & Brin, 
1992). With palliative care, however, the expectation is that drugs should be able to 
alleviate most pain, because the disease is progressive. Patients have significantly 
reduced life spans and are often too physically incapacitated to make the physical and 
mental adjustments that are possible, for example, for someone suffering from 
chronic lower back pain. This may explain the heavy reliance on pharmaceutical 
intervention, which requires minimal effort from patients. 
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The difference between the traditional role of a patient and the role supported 
by this present review can be described using a fourfold model of attribution of 
responsibility defined by Brickman and colleagues (Brickman et al., 1982). The 
model propqses the following categories of attribution of responsibility based on 
both the problem and the solution: moral, compensatory, medical and enlightenment. 
This model can discriminate the form behaviour takes when people try to help others 
or help themselves (See Table 1). 
The enlightenment model could be described as a correctional model, in 
which individuals must be punished and/or rehabilitated for their misdeeds. The 
traditional patient role obviously fits the medical model, in which people are seen as 
not responsible for either their illness or their cure and hence what they require is 
treatment from physicians. This model, if it is accurate, dictates that the role of 
physicians 
Table I 
Attribution of responsibility for the development of a problem and solution. 
Model/ Attribution Responsibility Requirement 
Enlightenment .. Problems only .. Discipline 
Medical .. Neither .. Treatment 
Compensatory .. Solutions only .. Power 
Moral .. Problems AND solutions .. Motivation 
(Brickman, Rabinowitz, Karuza, Coates, Cohn & Kidder, 1982) 
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and other health professionals is a paternal one and patients are expected to follow 
instructions and do not require explanations or choices, except as a courtesy. The 
preferences and opinions of patients are nominally involved, if at all, and it is 
difficult for patients to assert them (Brickman et al., 1982). 
It is argued here that the therapeutic effects of psychological intervention on 
the delivery of mainstream medical care extend beyond direct patient work to having 
the potential to improve the range of options offered to terminally ill patients and 
relieve a portion of the extraordinary responsibility that physicians traditionally have 
in nominating appropriate treatment. This is because change in the attribution of 
responsibility for problems and solutions alters the focus of what help is offered to 
the patient and how it is done. 
Psychologists are trained to work principally from a theoretical framework 
that fits either the compensatory or the moral model (Brickman et al., 1982), 
depending on the nature of the problem. In the former, people are not viewed as 
responsible for their problems, but are responsible for their solutions, and what they 
require is power to implement the expertise that professionals can offer and to utilise 
their own skills. This process of empowerment occufs by professionals working with 
patients to identify their goals and giving them the support and the information to 
realise them. 
The moral model postulates that individuals are responsible for problems and 
solutions and only require motivation. They are capable of proactive action and of 
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generating solutions, again, provided they are supplied with the expertise and the 
support to act. 
Palliative care patients could be described by both models, according to the 
identified problem. In the case of cancer patients, the moral model provides the best 
therapeutic fit. Patients are not responsible for causing the cancer, although their 
lifestyle may have contributed to it. They can make choices about treatment and 
about what they are prepared to endure and how far they will modify their own lives 
to deal with the cancer. 
For the problem of maladaptive or distressing emotional or cognitive 
responses to cancer or to pain, the distress can be described as self-generated, 
because of the particular perspective adopted by patients when they become ill and 
the illness becomes terminal. Cancer is a feared and common illness, but patients are 
capable of altering the way they view their cancer or their pain and thus diminishing 
the distress that results (Bannerman, 1992). Psychologists can offer a range of 
techniques, including cognitive therapies, which emphasise the contributions that 
patients bring to the physician-patient relationship. The movement away from the 
role. of victim-of-cancer provides a good environment for positive consequences for 
patients and for health professionals because responsibility for outcome is shared. 
This type of 'mutual participation' relationship between patient and professional, has 
been described as "the most effective physician-patient interchange that can occur" 
(DiMatteo, 1991, p. 194). 
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Chronic pain in terminal illness 
In modem times, improvements m medical techniques, disease control, 
sanitation and nutrition have resulted in longer life spans, with death from injury or 
opportunistic infections (AIDS and hepatitis being exceptions) becoming less 
predominant compared with 'lifestyle' illnesses such as heart disease and cancer 
(Lerner, 1984). Cancer is the leading cause of death after heart disease, both 
generally and for premature death (Australian Bureau of Statistics, 1992) and because 
cancer can progress slowly (Parkes, 1984), people with cancer comprise the largest 
group of patients in palliative care. 
The term 'cancer' refers to a category of diseases which vary significantly in 
their actions and aetiology (Hyde, 1988). All forms of cancer represent uncontrolled 
and disorganised cell growth, growing independently of surrounding tissue and 
having no value for the host. Environmental, personality and genetic factors have all 
been implicated in the aetiology of different categories of cancer and research into 
causation continues (Hyde, 1988; Thomas, 1993). Although the actual incidence of 
cancer is considerably higher than its mortality rate (depending on the type of 
cancer), its emotional impact is severe. Quite apart from the strong association 
people make between cancer and death (Lowenthal, 1990; Twycross & Lack, 1983), 
pain is considered to be the most feared side effect of cancer (Cain & Hammes, 1994; 
Hammes & Cain, 1994; Woodruff, 1993). This belief has intuitive appeal, although 
it has been argued that it is a misperception held by medical staff rather than patients 
(Charlton, 1994). This argument is a logical supposition, given that patients are more 
likely to express this particular fear to medical staff, who have the expertise to 
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control pain. Alternatively, it may be that the fear that is most salient for patients 
depends on their stage of illness. The most common fear has been suggested to be a 
fear of separation from the components of everyday life, such as friends, home and 
profession (Parkes, 1973, cited in Lichter, 1991) or concerns about family or 
becoming a burden (Dudgeon, et al., 1995). In fact, pain is likely to induce this type 
of separation, because it is a compelling distraction. 
Pain is one of the most common symptoms of advanced cancer (Walsh & 
Saunders, 1984), with significant pain occurring in approximately two-thirds of 
patients at this stage (Twycross, 1984). However estimates vary widely. Bruera 
(1993) argues convincingly that this variation is a natural consequence of the lack of 
uniformity among the methods of assessing pain and the views of the patients 
themselves. This highlights a particular difficulty, namely that pain cannot be 
measured objectively with any real confidence. 
Pain is a complex behaviour and not a simple sensation. The most frequently 
'referred to (see for example, Hoffert, 199~; WHO, 1986) and succinct definition 
.describes pain as "an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage" (Merskey & Bogduk, 1994). It is modified by the 
mind and is always subjective and unique to the individual (Merskey & Bogduk, 
1994; Woodruff, 1993). There is both sensory and affective processing within the 
central nervous system when a person experiences pain (Chapman & Gavrin, 1993). 
Psychological data suggest that higher brain functions are able to modify the patterns 
of nerve impulses produced by an injury (Holzman & Turk, 1986); hence 
psychological variables play a direct role in the pain experience. How a person 
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reacts to pain sensations is as important a variable as the specific physiological 
mechanisms involved in transmitting and generating pain experiences. 
In advanced cancer, pain is the most significant symptom (Patt, 1992). In the 
developed world, people are protected from pain to a large degree by the wide range 
of analgesia and anaesthesia available, so the unconscious expectation of the lay 
public is that all pain can be controlled. In situations in which this is not possible, as 
in severe chronic pain from arthritis or terminal cancer pain, the response of 
individuals is likely to be highly negative, unless they develop some sense of 
personal control and meaning in dealing with that pain: for example, if they operate 
from the perspective that their pain can act as a trigger for constructive action, such 
as altering medication, using relaxation, or active distraction, as opposed to being 
just unpleasant and unavoidable. Patients who perceive pain as a challenge have 
more positive reactions to it, such as less depression or reporting less pain, than those 
who view it as the enemy or a punishment (Barkwell, 1991). 
Chronic pain, whether benign or malignant, serves no biologically useful 
purpose and interferes with constructive behaviour, often occupying patients' whole 
attention. It is very different in character and meaning from much of the pain 
encountered in everyday life, and has a powerful impact on the psychological state of 
cancer patients. They can attribute pain to the malignancy even when it is unrelated, 
thus enhancing their emotional concern about the progression of the disease 
(Zimmermann & Drings. 1984). There is evidence to suggest that chronic pain 
patients develop specific psychological and physiological problems because of their 
inability to escape from their pain (Turk, 1996). Cancer pain can promote fatigue, 
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sleep disturbance, emotional distress, poor concentration and restricted movement 
(Chapman & Gavrin, 1993). Anxiety, dysphoria, hypochondriasis, depression and 
withdrawal are caused by the long term 'wearing down' effects. Gradual physical 
deterioration is the result of the effect of pain on sleep, appetite, behaviour and, 
frequently, the combined effect of multiple medications (Bonica, 1984). 
The reverse is also true, with psychological factors playing a major role in the 
way in which patients react to cancer pain (Lichter, 1991; Turk, 1996). This can 
form a vicious circle, exacerbating both conditions (Schreml, 1984; Zimmermann & 
Drings, 1984). In contrast, patients who are well informed about their treatment, and 
are confident in the skills and levels of concern in the professionals who work with 
them, are better able to tolerate pain which would be intolerable otherwise, 
particularly if emotional problems are not addressed (Shreml, 1984). 
Morphine and pain control 
The benchmark approach to pain control is_ the three step analgesic 'ladder' 
propounded by the World Health Organisation (1986) (e.g. Brooks, Gamble & 
Ahmedzai, 1995; McCaffery & Ferrell, 1995; Ripamonti & Bruera, 1996). In this 
model, mild analgesics such as aspirin or panadol form the first response to mild 
pain. Stronger pain requires mild narcotics such as codeine, with morphine being 
reserved for very strong pain. The effectiveness of these cardinal analgesics is 
heightened by combining them (e.g., morphine and panadol) and by the addition of 
other non-narcotic medications such as nonsteroidal anti inflammatories (NSAIDS), 
aniticonvulscents, antidepressants and tranquilizers, all of which are capable of 
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diminishing pain via different mechanisms (Ripamonti & Bruera, 1996; Twycross & 
Lack, 1983). Further flexibility is offered by the variation in dosage available for 
each component medication. In addition, patients can be offered an analgesic to take-
at their own discretion if breakthrough pain occurs (Twycross, 1984). This system 
offers significant opportunity for individualised pain control with morphine being 
capable of suppressing the strongest pain. It is the 'top rung' on the analgesia ladder. 
Worldwide, morphine is recognised as a powerful analgesic, well researched 
and widely available (Woodruff, 1993). It is the most frequently prescribed of all 
medications for strong pain (Brooks, Gamble & Ahmedzai, 1995; Lang, Beardon, 
Ladlow & Macrae, 1992; Lopez de Maturana, Morago, San Emeterio, Gorostiza, & 
Arrate, 1993). It is available in multiple forms, is well absorbed, provides long 
lasting relief and can be taken for long periods of time. Addiction rarely occurs, 
probably because of the slow rise in concentration of morphine in the blood when 
administered by sustained release preparations (Woodruff, 1993), and given the 
curtailed life span of terminally ill patients, the concerns about addiction have far less 
relevance than in the case of patients with chronic benign pain. Psychological 
dependence or 'pseudoaddiction' is more likely to be the result of previous poor pain 
control and/or incorrect prescription of opioids (Joranson, 1993; Zenz, 1993) and 
tolerance to morphine is usually mild (Woodruff, 1993). 
Unfortunately a number of common unpleasant side effects are associated 
with morphine use, such as vomiting, drowsiness, unsteadiness, mental confusion, 
constipation, sweating and depression. These side effects are well documented 
(Twycross & Lack, 1983) and with careful management, many such negative 
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consequences of using morphine can be avoided or at least diminished, provided the 
basic principles for administration are followed, thus alleviating the concerns of 
patients and their families. 
Individual dose titration and ongoing monitoring of morphine are crucial 
(Patt, 1992), due to the number of factors which affect the required dose. Different 
people experience pain of differing intensities and their thresholds of pain tolerance 
depend on variables such as cultural background, current mood, expectations, and 
previous history of pain control (i.e., whether pain was controlled satisfactorily or 
not) as well as the duration of treatment and the impact and severity of other 
distressing symptoms. Patients' use of co-analgesics and non-drug measures will 
also influence their morphine requirements (Twycross & Lack, 1983). Overuse of 
morphine can lead to toxicity which generates a range of highly unpleasant 
symptoms for the patient including mental confusion, disorientation, motor inco-
ordination, drowsiness, extreme constipation and nausea (Dunne, 1996). Inadequate 
prescription will lead to poorly controlled pain. Either condition is likely to increase 
patient distress and anxiety, which are further exacerbated if patient and physician 
have negative beliefs and expectations of morphine: for example, that it will cause 
dependency or addiction. I 
There is a variety of negative beliefs about the use of morphine amongst both 
professional staff (e.g., Twycross & Lack, 1983) and recipients. The latter may make 
associations between morphine and addiction, near death and euthanasia (Brasseur, 
Larue, Colleau, & Cleeland, 1993). For example, morphine has been regarded as a 
means of covertly achieving euthanasia (Lowenthal, 1990), or at least, 
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unconsciousness. The answers to this type of claim are better symptom control and 
better support offered to patients and their families, because a wish for euthanasia can 
be a reaction to the severe and unpleasant symptoms of an illness or its treatment, 
and to the belief that patients have nothing left to live for (Australian Psychological 
Society, 1996). One belief in particular relates to the longer term use of morphine for 
patients with inoperable cancer, where the opinion is that morphine should be saved 
for the final stages of patients' lives, regardless of the degree of pain they are 
experiencing before that time (Twycross & Lack, 1983). In fact, if it is used 
correctly, patients will not need rapid escalation of their dose for increased pain 
(Twycross & Lack, 1984). Some patients fear that morphine weakens the mind or 
the body and/or that it will make them die more quickly, but often the reverse is true, 
because good pain control allows patients to rest, sleep, and eat better which will, in 
turn, have positive repercussions on their overall quality and length of life. 
Australia ranks amongst the top 10 countries for per capita consumption of 
morphine, with all 10 being developed countries (Joranson, 1993). However, the 
literature indicates that cancer pain is seriously undertreated worldwide (Patt, 1992; 
Weinstein, Hill, Laux, Thorpe, Thomby, Vallbona, & Merrill, 1992), for example, in 
Germany (Zenz 1993; Zenz, Zenz, Tryba, & Strumpf, 1995), France (Brasseur, et al., 
1993) and the United States (McCaffrey & Ferrell, 1995). Prescription of morphine 
must be accompanied by intensive monitoring and paperwork in most countries. 
Such governmental control has the advantage of causing those who prescribe and 
those who ingest morphine to take it very seriously, but there is the corresponding 
danger that it will result in situations in which morphine could be used very 
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advantageously but is not, because of the difficulties associated with its use. 
Controls aimed at preventing illicit use have hindered or threatened to hinder 
appropriate opioid prescribing (Dahl & Joranson, 1992; Joranson, 1993; Shapiro, 
1994). Countries with more liberal laws for regulation of opioid use report higher 
levels of consumption, with no indication of increased misuse (Zenz 1993), which 
suggests that the restrictions used by some governments are not achieving their 
intending purpose and may, in fact, be hanning patients. 
In short, it can be demonstrated that the use of morphine for pain control in 
cancer is hindered by an aggregate of related factors, which could be expected to 
have repercussions on each other. These factors include governmental restriction, the 
limitations of professional knowledge and professional and patient prejudice. 
Alternative therapies for pain control 
Brickman et al.'s (1982) attributional models, described earlier, emphasise 
the indirect and often unacknowledged benefits, beyond the overt effects on stress 
and pain, that alternative therapies, in particular cognitive therapies, can provide. 
The emphasis is on choice and individualised therapies and on empowering and 
motivating patients, rather than 'fixing' the illness by· using treatments on (as 
opposed to with) them. 
This is not to be confused with forcing patients to become experts in 
oncology or psychology, regardless of their level of debility or cognitive skills. 
Patients may actively choose to leave physical treatment choices in the hands of 
others. The point is that they choose to do this, rather than having that position 
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forced upon them by the unconscious ethos of the professional treating them. 
Furthermore, they are professionally supported in directing their energies to issues 
such as emotional, financial and familial concerns, rather than just being left to deal 
with these concerns in the best way they can. 
Modification of life style, radiation therapy and nerve blocks are significant 
and frequently accessed non drug components of pain control for both benign and 
malignant chronic pain (Twycross, 1984; Twycross & Lack, 1984). It is logical to 
expect that simple physical interventions such as massage, hot or cold packs and 
positioning would be more regularly used to supplement medication, because they 
require minimal effort from the patient. By comparison, it is hypothesised that 
interventions which require cognitive effort from the patient, such as relaxation 
training, meditation and distraction, would infrequently be recommended by medical 
staff. Yet these are among the most portable and easily accessed methods of 
supplementing pain control, and, furthermore, they emphasise the choice and the 
active involvement of patients in their own palliative treatment. Given the crucial 
role of pain control in palliative care, and the less than perfect control available, 
augmentation of pharmacological therapy by techniques such as relaxation, imagery, 
massage and distraction is worthy of greater attention and implementation. 
There is evidence to encourage the use of cognitive-behavioural techniques 
such as guided imagery (Kearney, 1992), relaxation (Sloman, Brown, Aldana, & 
Chee, 1994) and distraction (Ellis & Spanos, 1994) to control or decrease pain. 
Hypnosis can alter both intensity and unpleasantness of pain in susceptible subjects 
and the magnitude of that intervention is increased if the hypnosis is also applied to 
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any concurrent anxiety (Dahlgren, Kurtz, Strube, & Malone, 1995). Magill-
Levreault (1993) summarises a range of research which supports the positive effects 
of music on mood, psychological and relaxation responses, and reports distraction 
from pain, reduction of nausea and vomiting, enhanced communication and a 
decreased need for postoperative pain medication. Melzack, Weisz, & Sprague 
(1963) demonstrated that people can learn to use auditory inputs (white noise and 
music) combined with suggestion, to decrease pain, in this case, having a hand 
immersed in ice water. The subjects in the study did not just passively listen, but 
attended to the music and noise, tracking the volume of one with the other, becoming 
actively rather than passively involved. 
These types of intervention may assist in improving patients' feelings of 
control over their lives (Turk, Meichenbaum, & Genest, 1983) and increasing their 
positive expectation concerning future pain or discomfort, each of which is likely to 
improve their tolerance of pain or discomfort (Bandura, 1989; Melzack, Weisz, & 
Sprague, 1963). People who have lived with a diagnosis of terminal cancer have 
different expectations of a 'successful' outcome than those with non terminal cancer. 
It alters their perception of self efficacy to have a terminal illness because, by 
definition, treatment options are directed at alleviating discomfort rather than at a 
cure. This will negatively impact on the coping strategies of patients and thus OD: the 
pain they may be experiencing. They will tend to rehearse cognitively negative 
experiences and in consequence the latter become more likely. If people's beliefs in 
their own coping efficacy are strengthened, they approach situations more assuredly 
and will make better use of the skills they have (Bandura, 1989; Turk, 1996). 
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Where patients have a high internal control over the course of their illness, an 
area cognitive-behavioural interventions could significantly augment, this is 
associated with the tendency towards a 'fighting spirit' and towards more positive 
characteristics in early stages of the disease, such as higher self esteem, higher social 
support, less anxiety and few negative feelings. These characteristics are further 
enhanced if the health professionals who work with them operate according to the 
compensatory model of attribution of responsibility discussed earlier in this paper. 
By comparison, patients who have a high internal control over the cause of cancer, 
regardless of disease status, are more inclined to experience an anxious 
preoccupation about the disease and a loss of control (Watson, Greer, Pruyn, & van 
den Borne, 1990). 
Many cognitive behavioural techniques are useful life skills, and provide 
general benefits from stress reduction, at a time in life when stress is likely to 
increase physical tension and interfere with both peace of mind and the immune 
system (Bernard & Krupat, 1994; Whitehouse et al., 1996). In addition, these 
techniques will positively impact on patients' subjective experiences of pain, with the 
stipulations that the patients are allowed to make an active choice of the alternatives, 
and that the chosen technique is clearly explained and individualised and delivered 
by an appropriately qualified individual. Basic psychological training states that 
techniques which are not delivered correctly may irritate or discourage the patient. A 
creative, interactive approach to supplement traditional pain control methods, based' 
on good communication with patients and their families, should be encouraged. An 
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individualised treatment is the best response to the person-specific experience of 
pain. 
A role for psychologists in palliative care 
The use of morphine in conjunction with non drug treatments, which include 
psychological support of the patient and family, is a logical pairing, given the dual 
nature of the experience of pain, namely, that the reporting of sensations experienced 
is modified by patients' emotional reactions to it. Negative affect particularly 
influences the way individuals perceive their bodies and bodily sensations. Koller, 
Kussman, Lorenz, Jenkins, Voss, Arens, Richter and Rothmund (1996) make this 
assertion with the implication that the health assessments made by examining and 
external physicians are more accurate than the subjective assessments of patients. 
However, if pain itself is defined as a subjective event, then it follows that patients' 
judgements of intensity and severity are more accurate than any 'objective' 
assessment. It is a principal flaw in physician-patient communication that 
professionals tend to believe they can assess pain better than their patients. 
The emotional reaction to pain is influenced b.y factors which include 
patients' feelings of self efficacy in coping with it, the general level of anxiety, anger 
and/or depression and expectations of pain (Twycross & Lack, 1983). In addition, 
Hodder and Turley (1991) include fatigue, relationship difficulties, communication 
difficulties, uncertainty, health system difficulties, side effects of treatment, non 
cancer pathology, loss of income and role and other unique patient aspects, such as 
previous experience of pain. Feelings of control, independence and self worth will 
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increase pain tolerance (Bandura, 1989; Chapman & Gavrin, 1993). These are areas 
that could be effectively targeted by psychological intervention .. 
With such breadth of considerations to take int,o account, it may often be 
difficult for patients to communicate the intensity of their subjective experience of 
pain. For a health professional to assess and treat pain with any accuracy, it is 
necessary to take all of these factors into account in acquiring a detailed pain history. 
To do this requires time, effort, experience and good counselling skills, which may 
explain why, in the domain of palliative care, this type of intensive assessment is 
often neglected (Cleeland, 1993). 
Unfortunately, medical wards in Tasmania tend to have a restricted range of 
psychological services available to support the type of intensive information 
gathering required for .a comprehensive pain assessment. Yet inadequate clinical and 
diagnostic pain assessment is the most obvious barrier to good pain control 
(Cleeland, 1993), followed by patients being reluctant to report symptoms (Janjan, et 
al., 1996). In palliative care, the serious nature of patients' illnesses emphasises 
attention on physical care. However, even if good quality physical care is available, 
the lack of skilled psychological intervention may contribute to patients' alienation, 
hopelessness and loneliness (Weisman, 1984). 
Ideally, palliative care is a form of treatment which is directed according to 
information provided by the patient. Medical practitioners must rely on their 
communication skills and experience to discover what they can about patients' 
subjective perception of pain. Those who have had no specific experience of or 
training in palliative care may pursue the goal of disease eradication beyond logical 
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hope of recovery and without the explicit consent of their patients. They may select 
treatment based primarily on aetiology, reported severity of pain and the patient's 
medical history, and not attend to patients' preferences or resources. Cain and 
Hammes (1994) comment that respecting patients' wishes involves considerably 
more than merely listening to what they say. The traditional approach, in which the 
beliefs and opinions of the professional do not incorporate the perspective of the 
patients, may be time efficient, but is ultimately alienating and disempowering for 
the latter, particularly where pain cannot be completely controlled. A patient-centred 
approach and the enhancing of patients' feelings of control, independence and self 
worth are highly likely to have a positive impact on their experience of pain and on 
their medical treatment overall. Psychologists have a definite role here in engaging 
psychosocial resources and teaching coping skills (Chapman & Gavrin, 1993). 
There is a wide degree of variability in what will constitute a high quality of 
life for each individual and for different stages in an individual's life. Physician-
patient communication must be operating efficiently to provide the best outcome for 
patients, but patients may not be able adequately to articulate their priorities and 
physicians may not have the resources to elicit them (Cleeland, 1993). This is an 
ideal arena for psychological intervention. Unfortunately physicians and patients 
rarely consider using psychological services in this manner, partly because of a low 
level of community awareness of what psychologists have to offer, particularly 
within the medical domain. Professional associations such as the Australian 
Psychological Society have a role to play in the provision of this type of information. 
Treatment of pain is ideally a joint effort which includes the beliefs and opinions of 
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the health professionals, the patients and their families. Those involved must be able 
to ask the right questions and convey the necessary information effectively. Lichter 
(1987) comments that effective communication is "the cornerstone not only to the 
management of anxiety, depression and a number of emotional problems, but also to 
the relief of pain and other symptoms" (p.1 ), and notes that poor communication 
causes more suffering in terminal illness than anything except unrelieved pain. 
Perhaps the frequent claim that cancer pain is undertreated (e.g., Weinstein et al., 
1992; WHO, 1990) is accounted for by the fact that many physicians and nurses are 
not fully familiar with a genuinely holistic approach to dealing with chronic terminal 
pam. 
Future directions for research 
Australia's history of palliative care is shorter than that of countries such as 
England and the United States, where there are comparatively sophisticated resources 
available to dying patients and their families (eg. Saunders). However, palliative 
care is now gaining recognition, and this recognition is likely to increase in the light 
of the current euthanasia debate. There are considerable ethical problems in offering 
euthanasia as a solution to suffering which could be contained by other means, such 
as multimodal pain control and a treatment approach which considers the mind 
equally with the body. 
The greatest contribution to patient well-being in terminal cancer care, for 
reasons outlined earlier, would be to augment existing pain control and this review 
suggests there are many domains which could be exploited to improve existing 
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techniques, many of which are in the realm of the behavioural sciences. The starting 
point for research in this area would logically be with the physicians, within whose 
domain pain control in cancer traditionally falls. By questioning the beliefs and 
opinions physicians have about the main concerns with and barriers to pain control in 
terminal cancer care and the degree to which they routinely consider simple 
alternatives to pharmacotherapy, it should then be possible to make informed 
decisions about where positive changes could realistically occur within the present 
system. 
Conclusion 
As the current generation of post war children ages and lives longer than their 
preqecessors, the next century is likely to see unprecedented numbers of people 
requiring palliative care. Currently, people are not always able to access specialist 
palliative care services. With the introduction of case mix as the principal funding 
determinant of hospital care, it will become increasingly important to consider 
.alternatives to hospital care and to facilitate the best use of community resources, in 
particular, general practitioners (GPs). Research in this field is particularly necessary 
in the case of smaller communities, in which resources are, and will continue to be, 
limited. 
Indications are that the role of psychologists and psychological care in 
palliative care will need to expand as technology becomes more sophisticated and the 
human life expectancy increases. The impact of psychological intervention, essential 
because of the impact of cancer on mind as well as body, is far more subtle than the 
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more obvious results of practical medical techniques such as surgery or 
pharmacotherapy. Thus professional psychological care is in danger of being 
overlooked unless it can be clearly demonstrated that it is both advantageous, and 
ultimately more efficient in the long term, to provide patients and families with more 
than straight medical treatment. In addition, this could lessen the pressure on GPs 
and diminish the problem of professional burnout caused by patients having overly 
high expectations of them. 
Ideally, all health care in the future will routinely integrate psychological with 
medical care, but in crisis situations this is particularly critical. The earlier 
psychological intervention is offered, the better the results are likely to be. 
Psychologists must actively promote the use of their particular expertise in advising, 
counselling, debriefing and providing cognitive-behavioural therapy. There is a very 
real limit to what can be achieved by one profession alone for a truly integrated 
system of cancer care, but this type of professional promotion serves as an acceptable 
preliminary. Psychology is an expanding discipline whose potential is only now 
beginning to be realised. In an affluent and sophisticated society in which humanity 
has the resources to provide people with genuinely holistic care which emphasises 
quality of life, psychological care is gaining in recognition. 
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Abstract 
This study questions the range of resources regularly accessed by Tasmanian general 
practitioners (GPs) in treating cancer pain and, in particular, their use of and attitudes 
to morphine, with a view to identifying new directions for cancer pain management. 
It is also concerned with which health professionals and services GPs access and the 
degree to which GPs suggest non-medical, non-pharmaceutical interventions. A mail 
survey of 236 GPs was carried out in Tasmania. The results indicated that GPs 
commonly use morphine to treat serious cancer pain in terminally ill patients, but are 
less united in their choice of medication for milder or non-terminal pain. 
Unexpectedly, GPs agreed that non-pharmacological interventions can assist pain 
management and had suggested such interventions to their patients. Interviews with 
12 patients and 10 carers in a specialist palliative care ward reinforced the view that 
psychological factors caused them considerable concern, whereas pain control was 
good. This research supports the proposition that psychologists working directly 
with patients and consulting with GPs would provide a substantial resource and assist 
in enhancing quality of life for patients with terminal illnesses. 
Palliative care has only come to widespread research and funding attention in 
recent years, as evidenced by the rapid increase in periodicals, publications and 
research funding (see, for example, New South Wales Palliative Outcomes Forum, 
1996). 'Palliative care' refers to the care offered to a patient suffering from a chronic 
deteriorating organic illness, when a cure is no longer achievable and the goals of 
care have shifted from disease eradication, to symptom relief and quality of life 
(World Health Organisation, 1996). The underlying assumption is that palliative 
care patients have a prognosis of six months or less to live (Dudgeon, et al., 1995). 
This study was designed to investigate factors which affect the satisfaction of GPs 
with pain control in terminally ill cancer patients. Specific areas of interest were 
barriers to patient access of morphine, non-pharmacological adjuncts to pain control 
and attitudes of physicians, patients and carers to methods of pain control. 
Morphine prescription was selected as a focal point of this investigation 
because it has been reported as the most effective and reliable medication for relief of 
strong pain and is widely available world-wide (Brooks, Gamble, & Ahmedzai, 
1995; Woodruff, 1993). Access to morphine is the first essential step in controlling 
many types of cancer pain. Its effectiveness in controlling pain is augmented by the 
addition of milder forms of analgesia, such as paracetamol and codeine, and other 
types of medication, for example, anti-inflammatory agents (Hodder & Turley, 1989; 
Twycross & Lack, 1983). The major disadvantages of using morphine are the side 
effects and fears held by the public about dependence and disguised euthanasia 
(Brasseur, Larue, Colleau, & Cleeland, 1993; Eccleston, 1997). The latter term 
refers to the belief that morphine may hasten death, unintentionally or otherwise. It 
was hypothesized that although terminally ill patients and their carers will tend to 
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express concerns about using morphine for pain control initially, their fears might be 
alleviated by experience of the drug. 
A number of researchers have explored attitudes and practices of GPs, nurses 
and/or patients towards the management of cancer pain and particularly the use of 
morphine both overseas, notably in the United Kingdom, and in Australia, but overall 
results are not clear. Morphine is the most frequently prescribed drug for severe 
pain, world-wide, but there is evidence that it is often not prescribed enough (Patt, 
1992; World Health Organisation, 1996). Also, knowledge of pain management in 
palliative care is less than optimal and many patients do not have the best possible 
pain control (Elliott, et al., 1995; Fife, Irick, & Painter, 1993; Hill, et al., 1991; Lang, 
Beardon, Ladlow, & Macrae, 1992; Lopez de Maturana, Morago, San Emeterio, 
Gorostiza, & Arrate, 1993; McCaffery & Ferrell, 1995; Wakefield, Beilby, & Ashby, 
1993; Wallace, Reed, Pasero, & Olsson, 1995; Zhukovsky, Gorowski, Hausdorff, 
Napolitano, & Lesser, 1995). 
Health professionals also have misunderstandings about morphine including 
commonly identified issues of tolerance, use predicated on prognosis rather than 
need, and the magnitude of inadequate pain management, (Elliott, et al., 1995; Fife, 
et al., 1993; McCaffery & Ferrell, 1995; Twycross & Lack, 1983). There is less 
concern about long term use of morphine in terminally ill patients than in patients 
with chronic benign pain (Polatin, 1996). Because GPs prefer to use morphine as the 
ultimate response to pain in the final stages of patients' lives (Twycross & Lack, 
1983), they might have more reservations about prescribing morphine to non-
terminal cancer patients compared with terminal patients. However, correct use of 
morphine will prevent the rapid escalation of tolerance even in non-terminal patients 
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(Twycross & Lack, 1984). Cautious prescribing of morphine on the basis of 
prognosis might account for the expressed concern that cancer pain is undertreated 
(Mccaffery & Ferrell, 1995; Weinstein, et al., 1992). 
In contrast to the concerns about tolerance raised above, no evidence of 
overconcem about opioid tolerance was found in a sample of South Australian GPs 
(Wakefield, Beilby & Ashby, 1993). There is, however, evidence of a lack of 
knowledge about good pain management practice particularly in those professionals 
who trained some time ago, (Boughey, cited in Lester, 1996; Brunier, Carson, & 
Harrison, 1995; Elliott et al., 1995; Fife et al., 1993; McCaffery & Ferrell, 1995). 
Side effects are expected and therefore are a frequent focus for medical intervention 
(Twycross, 1995), thus it was predicted that GPs might be more concerned about 
these than about tolerance or _dependence in prescribing morphine. 
Cancer is the leading cause of death in Australia after heart disease, and the 
incidence of cancer is increasing (Australian Bureau of Statistics, 1992). Effective 
control of strong pain should significantly improve the quality of life of terminally ill 
cancer patients, because pain has significant impact on the psychological state of the 
patient (Turk, 1996; Zimmermann & Drings, 1984) and often triggers or enhances 
related symptoms such as sleeplessness, inability to concentrate and nausea 
(Chapman & Gavrin, 1993). The incidence of pain in cancer is difficult to determine 
accurately, given the subjective nature of pain; estimates indicate that from one third 
to over two thirds of palliative care patients with cancer experience pain (Bruera, 
1994; Cleeland & Daut, 1982; Twycross & Lack, 1983; World Health Organisation, 
1996). Thus, in the public mind, cancer is not unreasonably associated with death 
(Lowenthal, 1990) and pain (Saunders, 1984; Woodruff, 1993). It was hypothesized 
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that GPs would identify pain as instilling greater fear than death in cancer patients. 
The prospect of unrelieved pain can be frightening and patients might be more 
inclined to refer to physicians with concerns about pain, directing fears about death 
to family or pastoral carers. 
CoI!1filunication is likely to be difficult for GPs who treat patients with 
terminal cancer because of the high level of emotion involved, the imminence of 
death and the many issues of grief and loss entailed, and because of the responsibility 
physicians carry in treating unpleasant physical symptoms and influencing the course 
of disease. A survey of GPs conducted by Wakefield et al., (1993) found that despite 
GPs general confidence in treating palliative care patients, the psychosocial needs 
and emotional distress of patients and their relatives were regularly identified as 
difficult issues. These issues call upon psychological rather than medical 
proficiency. It is hypothesised that GPs will report difficulties in communicating 
with patients and families and will find greater difficulty dealing with terminally ill 
patients than other patients. 
A basic component of good physicians-patient communication involves 
. routine provision of information about specifics of treatment and treatment options. 
One of the aims of this study was to determine the extent to which GPs routinely 
provide information about morphine, suggest supplemental techniques for pain 
control to patients and carers, and refer to psychologists for implementation of such 
techniques. If GPs do not see communication and counselling as their particular 
domain, they might assess pain control only in terms of pharmacological 
considerations. It is, therefore, hypothesised that most GPs will consider they are 
able to offer satisfactory pain control.· 
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Successful pain relief is a significant factor in decreasing the preoccupation of 
patients with their physical welfare, enabling them and their attendant health 
professionals to pay more attention to issues of psychological well-being (Saunders, 
1984), although the two aspects of care ideally operate concurrently rather than 
sequentially. For this reason it is valuable to assess the degree to which morphine is 
used by GPs in caring for cancer patients, and the concerns and problems that GPs 
may face in prescribing morphine. 
Patients in rural areas cannot always access palliative care units, either 
because they live too far away or because increasing demand on public health 
services means there is often a waiting list (Rothwell, 1996). Even in metropolitan 
areas, most patients continue to die at home, in general hospitals, or in nursing homes 
(Saunders, 1984). In Tasmania, a large proportion of the small population live in 
rural areas and are relatively isolated from mainland Australia. As a result, there is 
limited availability of specialist services, for example, there is only one specialist 
palliative care ward in the state. Given that cancer is relatively common and that 
significant pain occurs in many cancer patients, particularly in the later stages of the 
disease (Twycross, 1984), it is hypothesized that most Tasmanian GPs will encounter 
patients suffering from cancer pain. GPs often need to assist those who are unable or 
unwilling to use specialist services, and many GPs manage without help from these 
services (Lang, et al., 1992). Consequently, GPs are an essential component in 
palliative care (Wakefield, et al., 1993), and must provide an extensive range of 
services. However GPs have been identified as "a weak link" in the care of cancer 
(Lester, 1996), probably because so much is expected of them, from a specialist's 
knowledge of cancer to being on call at all hours. It is, therefore, hypothesised that 
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most GPs will have limited experience or formal training in palliative care despite 
regular contact with cancer patients. 
Because there is evidence that the public is inclined to regard morphine as a 
'dangerous drug' (Zenz, 1993), and to counterbalance the professional views of the 
practitioners (GPs), the views of 'consumers', that is, the patients, were also 
investigated. Thus, in addition to canvassing the opinions of GPs, a limited sample 
of terminally ill cancer patients was approached in order to explore their personal 
experiences of pain control, and, more specifically, their experiences of the impact of 
morphine on their pain control. Identified carers were also interviewed to broaden 
the perspective of each individual's experience. Patients were recruited from a 
specialist ward, in which they would be expected to be receiving the best palliative 
care available in the state and therefore their experiences are set in the context of 
quality medical care. 
This is a difficult population to access, given their physical frailty and the 
potential for emotional stress. The ethics of involving such people in research has 
been questioned (Bruera, 1994; de Raeve, 1994; Kristjanson, Hanson, & Balneaves, 
1994; Mount, Cohen, MacDonald, Bruera, & Dudgeon, 1995). However, provided 
that the research is conducted gently, guided by the wishes and experiences of the 
patients, involving them is not unethical. 
This exploratory study uses a broad approach to examine factors which have 
the potential to improve the terminally ill cancer patient's quality of life within the 




In summary, from the preceding review, the following predictions were 
made: 
Hypotheses relating to GPs 
• GPs will regularly encounter cancer patients suffering pain. 
• GPs will have limited training in palliative care. 
• GPs will have reservations about prescribing morphine to non-terminal cancer 
patients. 
• Side-effects of morphine will be of greater concern to GPs than dependence or 
tolerance. 
• GPs will prescribe morphine without routinely informing patients and their 
families about its properties and side effects. 
• GPs will report difficulties in communicating with patients and families. 
• GPs will report that more patients fear pain rather than death. 
• GPs will support the use of pharmacological, medical procedures alone rather than 
incorporating non-pharmacological non-medical interventions to supplement pain 
control, and will refer to health professionals other than psychologists for 
assistance in pain control. 
• GPs will report greater difficulty dealing with terminally ill patients than with 
other patients. 
• GPs will express the need for further education in pain and symptom management 
rather than counselling or communication skills. 
• Most GPs will report satisfaction with the pain control they can offer patients. 
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Patient/Carer Hypotheses 
• In a palliative care ward, patients and carers will express concerns about using 
morphine for pain control, .but their fears will be alleviated by experience. 
• Patients and carers will express general satisfaction with medication and most will 
describe pain as being under control. 
• Patients and carers will express psychological concerns relating to the terminal 
. medical condition. 
• Patients and carers will rely primarily on medical treatment for pain relief and will 





Three groups of participants were recruited for this research. The first group 
consisted of 467 GPs, who were contacted by letter using the current mailing lists of 
the Tasmanian Divisions of General Practice. Of the GPs contacted by letter, 236 
(50.5%) completed a questionnaire, 61 refused on the first contact and 22 refused in 
response to the reminder. In total, 319 (68%) of the target population made a 
response. Participants reported practising as GPs for between one and 54 years, with 
a median of 17 years. Sixty-eight percent had received their medical training in 
Australia, 23% in the United Kingdom and 9% percent elsewhere. Respondents were 
asked for a minimum amount of identifying information to encourage frankness and 
ensure confidentiality. Consequently, no details were acquired concerning gender, 
age or location of practice. 
The second group comprised 12 palliative care patients (7 males and 5 
females), out of a possible 36 patients admitted to the ward during the recruitment 
interval. The average ag~ of patients on the ward, according to a file review 
conducted between June 1993 and March 1994, was 63.6 years (Lord, 1995). Given 
the ethical concerns noted earlier, great care was needed in selecting and approaching 
patients, many of whom were unconscious or extremely weak, consequently, the 
number of patients included in this research was restricted. For this reason, the 
patient/carer interviews are presented as a pilot study. Patients were interviewed 
during their stay on a 10-bed palliative care ward, over a five week period. All 
patients were in the terminal phase of cancer and undergoing palliative treatment 
only. They had been admitted for one of three reasons: respite care, refining of 
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medication, or hospital support in the final days of life. Research inclusion criteria 
required a formal diagnosis of cancer and current or previous use of morphine. 
Primary tumour sites comprised roof of mouth (1), shoulder (1), lung (3), pancreas 
(1 ), bowel (1 ), colon (2), rectum (1) and Transitional Cell Carcinoma of the bladder 
(2). 
The third group was a sample of 10 identified carers (5 males and 5 fem~es), 
each of whom was nomimated by a patient as the person most involved with his or 
her daily life. This resulted in interviews with four spouses, four adult children, one 
sibling and one friend. A further two carers were uncontactable. 
Patients and carers all fulfilled the -study criteria of being over 18 years of 
age, mentally alert, able to speak and understand English and to provide written 
informed consent to participate in the study. Identifying information was kept to a 
minimum in both samples, in order to encourage participation and free disclosure of 
opinions. For this reason, no individual background information was collected, other 
than relevant medical information. 
Ethics 
This research received approval from the Royal Hobart Hospital Acute Care 
Program Research and Ethics Committees. 
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Materials 
GP Questionnaires: The questionnaire (Appendix A) was designed to elicit 
perceptions from GPs about selected issues relating to pain management in palliative 
care. Ideas and items from a number of previous surveys conducted in other states 
and countries were incorporated (e.g., Lang et al., 1992; Lopez de Maturana et al., 
1993; Wakefield et al., 1992), in addition to items created specifically for this 
research. 
The GP questionnaire presented 54 items grouped into 40 questions. 
Question format was varied with the majority of questions providing either multiple 
choice or yes/no responses. Five point Likert-type scales were also used for some 
items. These scales were presented in alternating order to compensate for any order 
effect. Open ended questions were only incorporated when a yes/no or multiple 
choice response was impractical. To increase response efficiency, questions with 
embedded items were used, with subordinate items being conditional on the response 
to the first item. 
The questionnaire opened with general items eliciting the respondents' 
relevant experience, training and frequency of contact with patients experiencing 
cancer pain. This was followed by questions relating to the control of cancer pain 
generally and then with morphine specifically, including typical consumer responses 
to its prescription and the identification of difficulties and advantages in using 
morphine for cancer pain in terminal and non terminal care. The focus of the 
questionnaire altered in the second part, from strictly medical to more holistic 
material, such as the frequency with which GPs accessed other health professionals 
in caring for cancer patients, use of non-pharmacological interventions, the degree of 
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difficulty GPs found in working with terminally ill patients, and what further training 
would benefit their practice. 
Patient/Carer Interviews: The interview schedules (Appendices D and E) 
were created to correspond in part to the GPs' questionnaire, and included a set of 
core questions in common with it (Questions 4, 7, 12, 14, 18, 22, 23, 25). These core 
questions were described in the preceding sections. 
The patient interview proforma consisted of 41 items grouped into 26 
questions. Question format varied, comprising yes/no, open-ended, multiple choice 
and one Likert-type scale. Large font (Times Roman 20 point, Appendix F) prompt 
sheets were used to assist respondents make their choices in multiple choice 
questions in which the number of choices exceeded three. Given the strict time 
constraints, embedded questions using 'yes/no' screens enabled the interviewer to 
direct the interview more efficiently to the areas applicable to each respondent. The 
first section of the interview contained questions for the interviewer to complete, 
including a short check-list to confirm patient eligibility. The patient's primary 
diagnosis and current medication were also recorded. 
The patient interview was designed to obtain details about the respondent's 
experience of morphine, to identify any prejudices and examine medication and pain 
control generally from the patient's perspeGtive. The focus remained on the 
individual experience of the patient. The interview began with questions about the 
respondent's experience of pain and satisfaction with medication. The next part of 
the interview concerned initial and current reactions to the prescription of morphine, 
previous experiences with it and the information given to them about it. Questions 
relating to the respondents' opinions about their overall medication were followed by 
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core questions which were replicated from the GPs' survey (Questions 22 to 25). 
These relate to non-pharmacological interventions to control pain, and what the 
respondent regarded as the greatest difficulty encountered while being ill. 
Carer interviews were designed primarily to provide confirmation and 
supplementation of patient responses, and did not differ in any significant respect 
from patient interviews. The principal difference was that carers were instructed to 
answer most items according to their perceptions of the patients' experiences. The 
structure of the interview was identical to that of the patient interview schedule, with 
two exceptions. Firstly, the section completed by the interviewer prior to speaking 
with carers did not include the p~tient's primary diagnosis and medication, but 
instead noted the carer/patient relationship. Secondly, the item referring to how 
medication for pain relief was administered was omitted since confirmation of this 
from carers was not necessary. 
Procedure 
General Practitioners: Questions were presented in a four page, double sided, 
AS booklet, and were primarily forced choice responses, but with some space for 
voluntary comments. The emphasis on forced choice was aimed at enhancing 
response speed in order to optimise the return rate from a frequently surveyed 
population and to facilitate coding. The questionnaire was designed to take 
approximately 10 to 15 minutes to complete. 
Respondents who identified themselves as never working with 
patients who had cancer and its resulting pain were instructed to discontinue the 
questionnaire as soon as that information had been established (Questions 4 & 5). 
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Those who never prescribed any type of narcotic analgesic (Question 9) were 
directed to resume the questionnaire where it returned to items not specifically 
related to morphine prescription (Question 28). 
The GP questionnaire was piloted on a sample of health professionals 
comprising four psychologists and four GPs. One-to-one discussions with members 
of the pilot group were conducted and reviews of specific comments received. As a 
result of feedback from the pilot study, amendments were made before the main 
mail out. 
Participants received an explanatory letter (Appendix B), a questionnaire, and 
a self addressed post paid envelope, followed by a reminder letter one week later 
(Appendix C). To maintain the confidentiality of the respondent, no record was kept 
of the names of those who did or did not complete questionnaires, therefore reminder 
letters were sent out to everyone unless GPs elected to identify themselves when 
returning the completed questionnaire or the refusal form. 
Patients/Carers: The scope of the patient interviews was restricted in 
comparison to the GPs' questionnaire, because of the constraints imposed by the 
infirmity of the sample. The patient contact time was designed to take between 10 to 
20 minutes. This time included explanations, obtaining consent, interviewing and 
debriefing. 
Prior to the commencement of data collection on the hospital ward, nurses 
were given an information session by the researcher, who had previously spent time 
on the ward in order to become familiar with the staff and routines. The nature of the 
research, its requirements and the type of patient sought were discussed and an 
I 
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opportunity was given for questions. An information summary sheet (Appendix J) 
reiterating key points was distributed during the session. 
To select appropriate participants in the inpatient sample, the researcher 
reviewed the daily list of patients on the ward and consulted with nursing staff in 
order to select patients who fulfilled the research criteria and to obtain information 
relating to their physical conditions and mental status. 
The P!Ocedure was devised to satisfy the most important ethical concerns 
raised by Kristjanson et al (1994) when interviewing a sample of terminally ill 
patients. Patients were given an explanation of the research and an information sheet 
(Appendix G). The researcher ma~e an informal assessment of the patient's mental 
status during this time, supported by file information and nurses' judgements. If the 
patient was regarded as suitable and agreed to participate, she or he completed two 
copies of a consent form (Appendix H) to enable both the researcher and the patient 
to retain a copy. Interviews were terminated immediately if there was any sign of 
discomfort or stress, or an indication of the wish to discontinue. To ensure consistent 
presentation the researcher conducted all interviews. When a multiple choice 
question was asked, the interviewer would ask the question and pause to allow the 
recording of any spontaneous answers. The response sheet was then presented, to 
provide suggestions or reminders. After completion of each interview the patient 
was offered the opportunity to comment or question. She or he was then asked to 
identify a carer and give permission for the researcher to send or leave a letter 
(Appendix I) with the patient, inviting the carer to complete a companion interview. 
Debriefing was provided if any issues raised in the interview warranted it. 
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Carers were interviewed as soon as possible after the corresponding patient 
interview, either on the ward or at home according to their preference. They were 
approached only by letter, and were asked to contact the interviewer or the ward to 
arrange an appointment or refuse. The interview procedure then continued in the 
same manner as for patients. 
SPSS (Statistical Package for the Social Sciences) for Windows 6.1 (SPSS 
Inc., 1994) was used to analyse the data. A variety of inferential statistics was used 
to analyse the data from the GP sample. It is acknowledged that the multiple 
statistical tests performed on the same data hav~ implications for a Type I error when 
considering the statistical significance ofresults. Totals varied throughout the GPs' 
data because not all respondents answered every question. The patient-carer sample 
was presented as a pilot study. Descriptive statistics were used for the patient-carer 
sample, due to the low sample size. The sample was further reduced to 10 patient-
carer pairs when numerically reporting patient/carer responses, to maintain 
consistency of data presentation. Interviews were content rich and consumers' 
personal experiences provided valuable i,nsights, therefore, individual comments 




The greater percentage (62.4%) of Tasmanian GPs encounter patients with 
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Figure I : Frequency of.GP encounters with cancer patients (Question 4). 
Over 86.3% of GPs report some or more frequent contact with patients who have 
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Figure 2: Frequency of patients with cancer pain seen by GPs (Question 5). 
Of the GPs who responded, 12.4% reported specialist training in palliative 
care which included attending lectures, correspondence courses, workshops or 
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seminars and postgraduate courses, and 34.2% had worked in a palliative care setting 
at some stage. 
Different medications are recommended according to the proposed aetiology 
of the cancer pain experienced (l.&W.M.D.G.P., 1995), therefore pancreatic cancer 
was specified when asking GPs about first choice analgesic agents. Morphine was 
chosen as the analgesic of choice for severe pain in pancreatic cancer by 7 4 .1 % of 
GPs. Choices for treatment of moderate pain in pancreatic cancer were more varied, 
ranging from aspirin to morphine, with paracetamol and/or codeine being chosen by 
55.3% of GPs. For 67.5% of GPs, paracetamol or aspirin were the first choice 
analgesic agents for mild pain in a case of pancreatic cancer. 
When comparing the degree to which GPs prescribe morphine for cancer, 
there was a significant difference between the mean reported frequency .with which 
morphine is prescribed between cancer patients generally and non-terminal patients 
specifically, according to the paired samples t-test (t(216) = 20.42, p < 0.01). GPs 
prescribed morphine more often for cancer patients generally (mean= 2.33, S.D. = 
.65) than for non-terminal cancer patients (mean = 3.39, S.D. = .73). Response 
categories were 'all' = 1, 'most' = 2, 'some' = 3, 'few' = 4, 'none' = 5. Non-
terminal cancer patients were considerably less likely to be prescribed morphine, 
with 66. 7% of GPs stating that they prescribed it for all or most cancer patients, 
compared with only 8.2% prescribing it for all or most non terminal cancer patients 
(see Figure 3). This result is statistically significant according to the McNemar's 
test <Siegel & Castellan, 1988) (x2 (1, N = 219) = 123.19, p < .001). More than a 
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Figure 3: Comparison of cancer patients and non-terminal cancer patients prescribed 
morphine by GPs (Questions 11 & 12). 
From Table 1 it can be seen that the control of side effects was the most 
frequently cited factor that interfered with optimum pain control, accounting for 
approximately a third of the responses. A further third of GPs noted that 
communication problems or misinformation to patients interfered with good pain 
Table 1 
Factors interfering with optimum pain control (Question 16). 
N % 
Control of side effects 64 30.0 
Communication problems 36 16.9 
Misinformed patients 28 13.l 
Patient denial 27 12.7 
Patient confusion 26 12.2 
Other/all/none 22 10.4 
Lack of resources 10 4.7 
Total 213 100.0 
control. The term 'patient denial' in Table 1 refers to the patient denying the 
existence or progress of their illness, or its effects. 
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It can be seen from Table 2 that a third of GPs perceived patient resistance, 
either to the initial prescription of morphine or its resultant side effects, as the 
greatest obstacle in using morphine for cancer patients. However, a small percentage 
(10.5%) encountered no major problem in using this analgesic. 
Table 2 
GPs' greatest difficulty using morphine with cancer patients (Question 18). 
Problem N % 
Patient resistance to prescription or side-effects 72 32.7 
Knowledge and development of side-effects 43 19.5 
Administrative difficulties in prescription 40 18.2 
None 23 10.5 
Prescribing dosage 21 9.5 
Knowledge of longer term use 10 4.5 
Other 11 5.1 
Total 220 100.0 
Table 3 lists the most common difficulties noted by GPs in treating cancer 
patients. Concerning the greatest difficulty in treating cancer patients, 3 8.1 % of GPs 
indicated 'treatment of other physical symptoms', compared with 15.6% who chose 
'treatment of pain'. Family problems accounted for over a quarter of responses on 
the list of difficulties. 
Table 3 
Greatest difficulty GPs encounter when treating cancer patients (Question 17). 
Problem N % 
Treatment of other physical symptoms 83 38.1 
Family problems 62 28.4 
Treatment of pain 34 15.6 
Other/all/none 34 15.6 
Giving information to patient 5 2.3 
Total 218 100.0 
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Table 4 shows aspects of treating pain with morphine which GPs have 
indicated are of concern to them. A higher percentage of GPs were more concerned 
about impairment of cognitive function and other side effects than about tolerance, 
and only a few were worried about dependence. 
Table 4 
Aspects of concern in treating pain in terminal cancer patients with morphine 
(Question 22). 
Area of concern N % 
Impairment of cognitive function 125 53.0 
Other side effects 98 41.5 
Tolerance 56 23.7 
Dependence 8 3.4 
Half of the GPs surveyed estimated that patients and families never or rarely 
objected to the prescription of morphine and 61.0% reported rarely experiencing 
difficulty with compliance when morphine was prescribed. However, a third of GPs 
(36.l %) noted that they sometimes had difficulty with compliance. The most 
common objection to the prescription of morphine was the fear that there would be 
nothing stronger to control pain if it should continue or worsen (23.8%). Concern 
about side effects was the next in importance (15.2%). GPs believed that, in 
comparison, families were more concerned about the possibility of patient addiction 
(27.5%). Cohen's kappa indicated similarity between what GPs believed patients 
objected to, and what their families objected to when morphine was prescribed 
(kappa = .41, p<0.01). Most GPs (95.6%) agreed they routinely give basic 
information about morphine to ,their patients, with 74.7% also indicating that they 
give information to the patients' families. This information is usually given verbally 
(92.9%) as opposed to written material or a combination. 
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In Figure 4 it can be seen that approximately two-thirds of GPs (67.6%), 
report that their patients fear pain more than they fear death. There were no 
differences in the mean levels of GPs' satisfaction with the pain control they can 
offer terminally ill patients (an ordinal/dimensional variable) across categories of 
patients' perceived fear (a nominal/categorical variable) as determined by a one way 
analysis of variance (ANOVA) (F(3,218) = 1.28, n.s.). There was no difference 
between whether nonpharmaceutical interventions were suggested or not for each 
category of GPs' satisfaction with pain control (t (212) = -.75, n.s.). Similarly, there 
was no difference between whether nonpharmaceutical interventions were suggested 
or not across the categories of the frequency with which GPs' patient base 
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Figure 4: GPs' beliefs about patients' fears of death and pain (Question 28). 
Overall, GPs reported being mostly or very satisfied (81.0%; 183 out of 226) with the 
pain control they were able to offer terminally ill cancer patients, with only 1.8% 
noting they were slightly satisfied or not satisfied. When asked about their resources 
for pain control, 79.6% agreed they were satisfied with them. 
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A large percentage of GPs (92.5%) stated that they had suggested non-
pharmacological interventions to supplement pain control medication, apart from 
radiation or chemotherapy. Of the entire sample, most GPs (74.7%) believed that 
some of this range of non-pharmacological interventions significantly assisted 
patients' ability to cope with pain, compared with 21.7% who did not. In addition, 
there was a positive correlation between those who had suggested these interventions 
and GPs who believed these interventions significantly assisted with a patient's 
ability to cope with pain (Pearson product-moment correlation = .28, 
p < .001). 
Table 5 summarises the frequencies and percentages of GPs who have 
suggested spe9ific non-pharmacological interventions. Relaxation was the most 
Table 5 
Non-pharmacological interventions suggested by GPs to terminally ill cancer patients 
(Question 34). 
Intervention N (%) Intervention N (%) 
Psychological Techniques 
Relaxation 168 71.2 Distraction 52 22.0 
Imagery 46 19.5 Active coping 45 19.l 
Thought stopping 23 9.7 
Practical Physical Interventions 
Massage 123 52.l Positioning 72 30.5 
Hot and cold packs 71 30.1 Movement 56 23.7 
Breathing techniques 36 15.0 
Alternatives 
TENS 175 74.2 Acupuncture 124 52.5 
Hypnosis 53 22.5 Naturopathy 18 7.5 
Laser therapy 14 5.9 Homeopathy 13 5.5 
Other 
Music 90 38.1 Art 7 2.9 
frequently suggested technique (71.2%), followed by acupuncture (52.5%) and 
massage (52.1%). In general, 20% of GPs had suggested some form of 
I 
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psychological therapy in the past, apart from relaxation, with other techniques being 
more variably accessed. 
In total, 62.3% of GPs reported that they referred to other health professionals 
at least sometimes to provide non-pharmacological intervention to augment pain 
control. It can be seen from Figure 5 that physiotherapists (53.0%; n = 125), 
psychologists (42.8%; n = 101) and nurses (43 .2%; n = 102) were the most 
commonly consulted. When GPs were asked to identify the services they regularly 
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Figure 5: Health professionals used by GPs to assist pain control (Question 36b). 
was a statistically significant, but low, negative correlation between how often GPs 
involved services other than palliative care in managing cancer pain and the 
frequency with which they referred to health professionals other than oncologists, 
radiotherapists and palliative care specialists for the provision of nonpharmacological 
interventions to supplement pain control medication (Pearson correlation = · -.25, 
p < .001). 
Overall, 97.4% of GPs reported palliative care services were available to 
patients in their area, with 88.6% indicating that they regularly referred to them. 
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Table 6 describes the frequencies with which GPs use services other than 
palliative care in managing cancer pain, and shows that almost a quarter of GPs 
surveyed involve them always or frequently and a third sometimes use such services. 
Table 6 
Frequency of GPs' use of services other than palliative care in managing cancer pain 
(Question 38). 
Frequency N reporting using Percentage 
other Services (%) 
Never 16 7.2 
Rarely 71 32.1 
Sometimes 83 37.6 
Frequently 48 21.7 
Always 3 1.4 
Total 221 100.0 
Most used services were identified as district and community nurses (3 7. I%), 
specialist doctors (11.3%), clergy (6.2%), and a pain clinic (4.1 %), with other 
services each accounting for less than 3% of the responses. 
In Figure 6, it can been seen that on the subject of doctor-patient interactions, 
42. 7% of GPs expressed the belief that it was more difficult dealing with terminally 
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Figure 6: GPs' responses when asked whether terminal patients were more difficult 
to deal with compared with other patients (Question 39a). 
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energy required ( 23.2%) and 16.8% noted the difficulty of dealing with the emotion 
involved. However, 48.6% reported that dealing with terminal and non terminal 
patients was equally difficult. 
When questioned about professional development, at least half of all GPs 
surveyed indicated further training in some aspect of palliative care would benefit 
their practice. Table 7 demonstrates that control of pain and other symptoms are the 
most popular topics, but over a third of all respondents expressed interest in each of 
the topics presented. Only about 10% of GPs indicated that none would be useful. 
Table 7 
Professional development topics GPs consider would benefit their practice. 
(Question 40). 
Professional development topic Topic beneficial Percentage 
(N=GPs) (%) 
Non-pharmacological methods of 
supplementing pain control 125 53.0 
Control of other symptoms 122 51.7 
Cancer pain management 114 48.3 
Bereavement counselling 107 45.3 
Communicating with dying patients 97 41.1 
Access to advice from practitioners 
experienced in palliative care 97 41.1 
None of these 23 9.7 
Table 8 displays the results of independent samples t tests comparing GPs' expressed 
beliefs about whether professional development topics would benefit their work or 
not, according to their number of years in practise. · The GPs who believed that 
'cancer pain management' was a beneficial topic had a longer mean length of service 
(21.37 years) than those who did not (18.68 years), but the difference narrowly failed 
to reach statistical significance (t(224) = 1.93, p = .055). GPs who identified 'control 
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of other symptoms' as a topic beneficial to their practise had a shorter mean number 
of years in practise (18.44 years) than those who did not (21.54 years) (t(211) = 2.23, 
p < .05). A separate variance t-test was employed for this topic because Levene's 
test (Levene, 1960) indicated that the group variance was significantly different from 
each other 
(p < .01), violating the assumption of the standard t-test (Ferguson & Takane, 1989). 
Table 8 
Independent samples t-tests comparing perceived benefit of professional 
development topics (yes/no) on GPs' number of years in practise. 
(Questions I and 40). 
Benefit Years in practise 
Professional development GPs 2-tailed 
topic practise Mean S.D. N t-value significance 
Cancer Pain Management Yes 21.37 10.59 108 1.93 .055 
No 18.68 10.39 118 
Control of Other Yes 18.44 9.30 115 -2.23 * 
Symptoms No 21.54 11.54 111 
Communicating with Yes 20.77 10.67 91 .94 n.s. 
Dying patients No 19.42 10.48 135 
Bereavement Yes 19.28 9.95 101 -.88 n.s. 
Counselling No 20.52 11.02 125 
Non-Pharmacological Yes 18.81 10.16 118 -1.72 .086 
Methods of Supplement No 21.22 10.87 108 
-ing Pain Control 
Access to Advice from Yes 20.41 10.42 91 .52 n.s. 
Practitioners Experienced No 19.67 10.67 135 
in Palliative Care 
None of these Yes 22.05 11.90 22 .97 n.s. 
No 19.74 10.40 204 
• p < .05 
Finally, there was no significant difference in mean length of service of GPs who 
believed that 'non-pharmacological interventions of supplementing pain control' was 
a beneficial topic and those who did not (t (224) = 1.72, p = .086). 
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There was no significant association, as assessed using the chi-square test, 
between GPs who had specialist training in palliative care (yes/no) (Question 3b) and 
their choice of professional development topics (beneficial/not beneficial) (Question 
40), or in those who believed that none of the topics would benefit their practise. (See 
Table 11 in Appendix K). 
The above results are concerned with individual prurwise correlations 
between a range of variables and the degree of satisfaction which GPs have with the 
pain control they are to offer terminally ill cancer patients. In order to examine the 
relationships between several of the above range of variables taken together and the 
degree of satisfaction which GPs have with the pain control they are able to offer 
terminally ill cancer patients, a multiple regression/correlation analysis (Cohen & 
Cohen, 1983) was performed as an extension of the individual correlations. 
This analysis employed the backward elimination approach (Miller, 1990). 
Initially all the variables selected by the researcher were entered. At each step the 
variable with the lowest F statistic was removed from the model, if the F statistic was 
not significant at the .10 level (the SPSS for Windows default) to allow for variables 
that may not be statistically significant by themselves but may be more effective 
predictors when combined with others. 
Pearson correlations were firstly calcul1:1.ted between the individual variables, 
"ENCOUNTER" (how frequently GPs encounter patients with cancer; Question 4), 
"CANCERP AIN" (how frequently GPs saw patients with cancer pain; Question 5), 
"PROPORTION" (the proportion of cancer patients GPs prescribed morphine to; 
Question 11 ), "NONTERMINAL" (the proportion of non-terminal patients GPs 
prescribed morphine to; Question 12), "RESERVATIONS" (the reservations GPs 
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had in prescribing morphine to non-terminal patients; Question 13), 
"INFORMATION" (whether GPs routinely gave patients basic information about 
morphine; Question 29), "NONPHARMl" (whether GPs ever suggested non-
pharmaceutical interventions to supplement pain control medication Question 34), 
"NONPHARM2" (whether GPs considered non-pharmaceutical interventions 
significantly assisted patients in coping with pain Question 3 5), "PALLIATIVE" 
(whether there were palliative care services available to patients in the area; Question 
37), "HOWOFTEN" (how often GPs involved services other than palliative care in 
managing cancer pain· Question 38) "TOPI Cl" "TOPIC2" "TOPIC3" "TOPIC4" 
' ' ' ' ' ' 
"TOPICS", "TOPIC6", "NOTOPIC" (whether any of the following topics would 
benefit GPs' practises - cancer pain management, control of other symptoms, 
Table 9 
Pearson correlations between potential predictor variables for the degree of 
satisfaction GPs express regarding the pain control they are able to offer terminally 
ill patients ("SATISFY''). 
Variable name Correlation with Significance 
satisfaction (r) (p) 
ENCOUNTER .17 * 
CANCERPAIN .08 n.s. 
PROPORTION .20 ** 
NONTERMINAL .17 * 
RESERVATIONS -.11 n.s. 
INFORMATION .11 n.s . 
NONPHARMl . 05 n.s. 
NONPHARM2 -.01 n.s. 
PALLIATIVE .03 n.s . 
HOWOFTEN . 10 n.s. 
TOPIC 1 -.13 * 
TOPIC2 -.12 n.s. 
TOPIC 3 -.08 n.s. 
TOPIC4 .03 n.s. 
TOPIC 5 -.04 n.s. 
TOPIC 6 -.19 ** 
TOPIC 7 :16 * 
* p < .05 ** p < .01 
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communicating with dying patients, bereavement counselling, non-pharmaceutical 
methods of supplementing pain control, access to advice from practitioners 
experienced in palliative care or none; Question 40), and "SATISFY" (the degree of 
satisfaction GPs express regarding the pain control they are able to offer terminally 
ill patients; Question 32). Correlations are given in Table 9. 
The multiple regression selected six variables, shown in Table 10. The final 
model accounted for 13.85% of the variance (r2 = .1385, F (6,186) = 4.98). The 
strongest predictor of satisfaction with pain control was the item which stated that 
none of th,e topics suggested for professional development would benefit the practise. 
The proportion of cancer patients GPs prescribed morphine to was also a predictor of 
satisfaction. It is not necessarily intended that the above variables be employed to 
predict satisfaction. The six variables taken together do however account for greater 
variance in satisfaction than the best of the individual variables (PROPORTION) (r2 
= .1385 vs r2 = .04 respectively). 
Table 10 
Variables selected by backward elimination multiple regression as contributing to the 
variance of how satisfied GPs are with the pain control they are able to offer 
terminally ill patients. 
Variable name Beta t-value 2-tailed 
significance 
PROPORTION .1604 2.03 * 
NONTERMINAL .1148 1.66 n.s. 
NONPHARMl .3576 1.91 * 
TOPIC4 .1651 1.69 n.s. 
TOPIC6 -.2128 -2.16 * 
NOTOPIC .4547 2.56 * 
* p < .05 
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Patients/Carers 
Caution needs to be exercised when interpreting the following data because of 
the small sample size. For this reason, verbatim quotes were utilised in addition to 
simple statistical comparisons. The data represent a pilot study only and only 
attempt to explore patient and carer responses to morphine, pain control and 
nonpharmacological interventions within this narrow context. 
All patients were taking multiple medications (range= 8 - 14) at the time of 
the interview. All were on morphine, with the length of use ranging from 1 day to 13 
months. Nearly every patient (n = 11) was prescribed laxatives and/or stool softeners 
and most (n = 8) were also prescribed simple analgesics such as paracetamol. Other 
medications included anti-inflammatories, anticonvulsants, diuretics, sedatives, 
hypnotics, antidepressants, anti-anxiety agents, and agents to enhance gastric motility 
or inhibit secretions. Anti-inflammatories, antidepressants and anticonvulsants assist 
in the control of certain types of pain, in addition to their more common function 
(l.&W.M.D.G.P., 1995; Kinney & Brin, 1992). 
Reactions to the initial prescription of morphine were mixed, and there was 
evidence from both patients and carers of prejudices against its use. Overall, three 
times as many carers as patients expressed positive reactions to the initial 
prescription of morphine, with two patients making positive comments and the rest 
being evenly divided between neutral and negative comments. There was no 
agreement between patients and carers when asked whether they or the patient/their 
families had ever worried about the patient taking morphine. 
Some patients and carers stated that relieving the pain was their primary 
concern "Very pleased to give it (morphine) to him. I knew it would stop any pain" 
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(Carer). I was worried more about the cancer than the morphine" (Carer). "It's a 
case of anything that would help would be better" (Patient). Others spoke of 
relinquishing control to their doctors: "I just agreed to whatever the doctor 
suggestecf' (Patient). "I leave it to them (doctors). They know what they're doing." 
Negative comments included the following: "I fought against it (using morphine). I 
thought I'd become addicted' (Patient). " ... apprehensive. I thought his pain must be 
greater than it appeared to me" (Carer). Several people indicated they believed the 
prescription of morphine held implications for the prognosis: "Perhaps this is the 
beginning of the encf' (Patient). "Things must be pretty bad if she had to take such a 
strong drug/or pain relief' (Carer). 
When asked "How do you feel about morphine now?", all patient and carer 
comments were either neutral or positive. When asked specifically what were the 
concerns about being prescribed morphine, interviewees had much less to say. Most 
of the patient and carer sample indicated they had received information about 
morphine (carers: 60%, patients: 70%). The information was most often given by a 
doctor (carers: 50%, patients: 70%), and questions were generally answered to their 
satisfaction (carers: 60%, patients: 80%). Over a third of carers (carers: 40%, 
patients: 20%), stated they had not had any questions to ask about morphine. 
Seven out of nine patient-carer pairs indicated that they were satisfied with 
the medication the patients were taking. Two patients were not, but their carers were, 
(carers: 90%, patients: 80%) and two out often patient-carer pairs agreed they would 
not change anything about the medication if they could (carers: 60%, patients: 50%) 
and one pair agreed that they would. Three patient-carer pairs agreed that the 
patients needed the amount of medication they were currently receiving, compared 
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with one patient-carer pair who did not (carers: 60%, patients: 60%). On the 
question of pain control, eight patient-carer pairs agreed that the patients' pain was 
under control, and none agreed that it was not (carers: 70%, patients: 100%). Where 
pain was not thought to be controlled, patients and carers indicated they would prefer 
no medication at all, or that it was not working well. Half the sample of patients and 
carers (carers: 60%, patients: 50%), stated they believed the medication caused side 
effects. Of these, three patient-carer pairs agreed there were side-effects and two 
agreed there were none. Constipation was viewed as the most problematic side effect 
by 50% of patients, whereas 55.6 % of carers (5 out of 9 non missing) commented 
that none of the side effects caused problems; six pairs agreed it was a problem while 
one pair agreed it was not. 
Patients and carers were asked to identify the greatest difficulty encountered 
while being ill. The responses included treatment of pain (carers: 20%, patients: 
30%,), family problems (carers: 30%, patients: 10%), treatment of other physical 
symptoms (patients: 20%), loss of independence (patients: 20%) and no particular 
problems (carers: 20%). 
Inspection of the data indicates that cognitive strategies and other methods of 
augmenting pain control were not suggested by medical staff (carers: 80%, patients: 
80%), and that patients and their carers made use of only a few techniques. 
Temperature (i.e., hot or cold packs) were the most frequently identified (carers: 
50%, patients: 40%), and others included massage (carers: 40%, patients: 20%), 
acupuncture (carers: 30%, patients: 20%), relaxation (carers: 10%, patients: 10%), 
distraction (carers: 20%), breathing (carers: 10%, patients: 20%), music (carers: 20%, 
patients: 10%), naturopathy (carers: 20%, patients: 10%), and movement (carers: 
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20%, patients: 10%). When asked what other techniques had been tried, use of 
alcohol (carers: 10%, patients: 20%) and ignoring the pain (carers: 10%) were 
acknowledged. 
In Figure 7, it can be seen that opinions about the effectiveness of non-
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Figu,re 7: Belief of patients and carers that cognitive techniques would help 
them to control pain (Question 24). 
massage, distraction, active coping, temperature, hypnosis, TENS, positioning, 
movement, music, naturopathy, art therapy, laser therapy, homoeopathy and · 
acupuncture), were evenly distributed overall. Generally speaking, more carers 
(70%) expressed greater confidence in cognitive coping strategies than patients 
(20%), over half of whom were undecided (60%). Two patient-carer pairs agreed the 
strategies helped to control pain and three agreed they did not. 
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Discussion 
The results of this study generally support Wakefield et al.'s (1993) 
contention that GPs are an essential component in palliative care, because they 
regularly encounter patients with cancer, many of whom experience pain, although 
results need to be treated with caution. The ,following hypotheses were supported by 
the study: Few GPs reported specialist training or placements in palliative care, 
although most indicated palliative care facilities were available and that they 
regularly referred to them. Morphine was regularly prescribed for severe cancer pain 
with a much greater range of choice evident for moderate cancer pain. This overall 
trend is in accord with the World Health Organisation (W.H.O.) ~algesic ladder 
(W.H.O., .1996). GPs did report reservations about prescribing morphine to non-
terminal cancer patients and prescribed morphine to a smaller proportion of non-
terminal compared with cancer patients as a whole. Tolerance and/or dependence 
were considerably less frequently identified as aspects of concern for GPs, which is 
consistent with previous research in Australia (Wakefield et al., 1993) and with 
expert opinion that tolerance will not occur if morphine is properly prescribed 
(Twycross & Lack, 1984). 
Looking at the results as a whole, the data support the proposition that GPs 
regard morphine as a satisfactory response to. pain in terminal cancer patients but 
many perceive that consequent side effects and patient responses such as resistance, 
denial, misinformation and communication problems complicate appropriate delivery 
of morphine. In spite of this, GPs were 'mostly satisfied' with the pain control they 
were able to offer terminally ill cancer patients and with their resources for pain 
control generally. Morphine was less acceptable for non-terminal patients despite the 
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fact that severity of pain rather than prognosis is considered to be the most 
satisfactory determinant of morphine use (Hodder & Turley, 1989; W.H.O., 1996) 
and that this belief in use predicated on prognosis may contribute to undertreatment 
of cancer pain (McCaffery & Ferrell, 1995; Weinstein et al., 1992). Most GPs did 
report they believed patients feared pain more than death. Consequently, according 
to the perspective of many GPs, addressing factors other than patient access to 
morphine could improve quality of life in terminally ill cancer patients. It would be 
interesting to pursue this question in a large patient sample and determine whether 
patients themselves confirmed this belie£ 
The hypothesis that GPs prescribe morphine without routinely informing 
patients and their families of its properties and side effects was not supported in this 
research, although the quality of the information given was not assessed and in most 
cases it was delivered only verbally and was therefore more easily forgotten. 
Contrary to the hypothesis, most GPs recorded that they did suggest non-
pharmacological interventions to supplement pain control medication and most also 
agreed that they believed some of these interventions significantly assisted patients' 
ability to cope with their pain, however there was only a low correlation between 
these two items. This suggests either that those who believed in the utility of 
supplementary interventions did not tend to recommend them, or that they suggested 
these techniques for other reasons. In addition, GPs indicated that they did 
sometimes use psychologists for the provision of non-pharmacological interventions 
and only physiotherapists were more frequently identified. It is worth noting 
however, that when asked who they regularly involved in their management of 
cancer pain, only one doctor identified psychologists. 
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The hypothesis that GPs would identify terminally ill patients as more 
difficult to deal with than other patients was not supported, although a substantial 
number did agree with the statement. Finally, although topics related to direct 
medical care were the most frequently selected professional development topic, many 
GPs indicated that bereavement counselling and communication would benefit their 
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practises. Overall, GPs appeared to be willing, in theory, to incorporate psychosocial 
dimensions into their care of terminally ill cancer patients and to involve 
psychologists and psychological interventions. 
Patient and carer hypotheses were generally supported. The interviews 
supported the hypotheses that patients and carers had concerns about the prescription 
of morphine, and that many of those concerns dissipated with actual experience of 
the drug. The quantity of medication patients were consuming rendered their 
judgements about morphine alone oflimited value objectively, given that side effects 
and pain control could be attributable to interactions with other medication, and the 
course of the illness. However, these judgements are useful in so far as they are 
likely to pertain to the subjective, psychological impact of the drug and the overall 
effects attributed to it and results from the GPs' questionnaires suggest patient 
prejudices or misconceptions about morphine are a concern .. 
From the consumer's perspective, medication and pain control was largely 
judged satisfactory, which would be expected from patients on a specialist ward. 
Carers expressed more positive attitudes to morphine than patients, but patients' 
opinions of morphine either improved or remained neutral after experience of it. 
Multiple psychological concerns were elicited from patients and carers, which 
support the claim that for some palliative care patients and their carers psychological 
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concerns supersede the more obvious physical ones. Non-phannacological 
interventions were not frequently suggested by medical staff nor used to supplement 
pain control and carers expressed higher levels of belief in the efficacy of such 
interventions than patients. Agreement between patient and carer expressed beliefs 
was generally poor. This insinuates that communication between patients and carers 
may be flawed, given that both interviews were primarily focussed upon the patients' 
experiences. 
GPs are likely to be the first professional contact for patients diagnosed with 
cancer. For patients who prefer to remain at home through the course of their illness, 
knowledge about pain management and the communication skills of practitioners 
play a large part in the quality of life they experience after the disease is diagnosed 
(I.&W.M.D.G.P., 1995; Twycross 1995). Yet the current results have also indicated 
that many of the GPs in Tasmania have limited training in palliative care and are 
interested in further education on both medical and more multidisciplinary topics. 
Given the vulnerability of terminally ill patients and their carers, greater expertise on 
behalf of practitioners, particularly in considering psychological support for and 
empowerment of patients and carers, can only benefit them when there is evidence to 
suggest that cancer pain is undertreated and medical staff susceptible to inaccurate 
information (Patt, 1992; Elliott et al., 1995; Fife et al., 1993; Lang et al., 1992; 
Wakefield et al., 1993). 
Morphine is commonly prescribed, although the data from all quarters 
indicated that there are concerns about its prescription. Side effects are a particular 
concern, however the deleterious effects of negative patient factors.were also referred 
to. This result emphasises the value of good doctor-patient communication, which is 
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further borne out by the fact that problems concerning the family were identified by 
almost a third of the sample of GPs as the greatest difficulty in treating cancer 
patients. This category of problems is particularly likely to benefit from clear and 
effective communication between doctors and patients/carers. Faith in the provision 
of medical services and opinions will diminish the anxiety and misunderstanding, in 
addition to doctor-patient communication contributing to satisfaction with pain 
control (Zhukovsky et al., 1995). The data provide some support for the proposition 
that the quality of life of cancer patients would be likely to be improved with greater 
training in, and support for, communication skills for GPs, together with input by 
other professionals. However, medical topics were more frequently selected, rather 
than counselling or communication skills, as potentially beneficial by the GPs 
themselves. This may mean that although these issues of 9ommunication can 
represent difficulties for GPs, either they are not perceived to be critical problems, or 
GPs do not regard these skills as being within their professional responsibility. 
Further research would be useful in clarifying this issue. 
Most GPs reported providing information about morphine to patients, yet a 
large number of GPs cited patient resistance to either morphine or fear of its side 
effects as the most significant problems in prescribing morphine, implying the 
message is unsuccessful. Also, patients and carers were usually unable to report 
details of the information, if any, that they had been given by doctors about 
morphine. Future research could explore the relationship between information 
provided by GPs and patient attitudes to morphine. 
In spite of the many difficulties identified by the GPs, most reported being 
satisfied with the pain control they were able to offer their patients and the resources 
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they were able to access. The da~ indicated that GPs reporting that none of the 
suggested palliative care topics would benefit their practise, was predictive of their 
overall satisfaction with pain control in terminal cancer patients. Similarly, the 
variables relating to the proportion of patients GPs prescribed morphine to and 
whether GPs suggested alternatives to medical pain control also contributed to the 
variance of GPs' satisfaction with pain control. GPs did not frequently endorse 
alternative therapies as adjuncts to pharmacotherapy. However, it was not within the 
scope of this study to assess how often these alternatives were used or how 
professionally they were applied. The term 'relaxation', for example, can define a 
range of events from listening to a recording of relaxing music to an individualised 
session of muscle relaxation guided by an experienced professional. It was 
encouraging to note that many GPs believed that non-medical procedures 
significantly assisted patients' ability to cope with pain, because these techniques 
offer choice and can enhance feelings of self-efficacy in patients. 
The patients interviewed for this research had access to highly specialised 
care. Admission to the palliative care ward was an indication that pain or other side 
effects were causing problems, or that they were close to death, which characterises 
this patient sample as particularly vulnerable. As might be expected, in this 
environment, the overall level of satisfaction with medication was high and most 
patients and carers reported that pain was under control. Side effects were identified 
as problems, but were rarely selected as the greatest· difficulty encountered while 
being ill. There was clear evidence of initial patient concerns about the prescription 
of morphine in this restricted sample, but with experience of the drug and the 
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continuing feedback from doctors that many had received, these concerns appeared to 
be largely neutralised. 
Although the quality of care was high in the ward sampled in this study, as 
evidenced by patient : staff ratios and patient and carer feedback, patients were 
offered few alternatives to medication for pain control. The alternatives offered 
included relaxation tapes, distraction, spas, heat and cold packs, physiotherapy, 
pastoral care yisits and positioning. Given the seriousness of the patients' disease, 
the advanced age of most and the short duration of the average stay, many non-
pharmacological alternatives are less helpful in this environment than they would be 
at an earlier stage in the illness. Nonetheless, modified forms of intervention could 
be adapted to fit the special conditions of very debilitated patients in order to enhance 
medical control of pain and/or other unpleasant symptoms, such as smell, itching or 
constipation, to relieve boredom or stress and to improve the experience of being in 
hospital. These alternatives include customised relaxation, thought stopping, 
imagery, goal setting, cognitive reframing and counselling to deal with issues that 
could be affecting pain perception, such as grief and loss of independence. Many of 
these techniques are equally appropriate for carers, given both patients and carers 
expressed concerns about how families were coping with the illness. D~spite high 
levels of unpleasant physical symptoms and terminal prognoses, some patients and 
carers indicated they were more troubled by psychological concerns, which supports 
Lichter's (1991) beliefs. 
One of the major difficulties inherent in using patients from a hospital setting 
as part of a research sample is that patients may feel dependent on the ward and 
consequently unwilling to criticise any aspect of their care, including their 
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medication and further, patients may feel they have to participate in research because 
of their need for care. Kristjanson et al (1994) commented that this poses an ethical 
problem when including a patient sample in palliative care research. It is nonetheless 
ethical and practical to continue to return to the patient population for consultation 
when hypothesising about what constitutes good palliative care, particularly if 
research is designed with these limitations in mind. 
A future study might undertake to interview terminally ill and non-terminal 
cancer patients in the community who are being treated by GPs, to look at the 
differences in their attitudes and experiences of pain control. A matched sample of 
patients and their doctors could provide interesting comparisons of patients' care 
from the two perspectives. It would be particularly valuable to look at the population 
of patients in an area outside the jurisdiction of a palliative care ward, who have poor 
access to specialist services, because such a ward often acts as a resource centre for 
GPs in the surrounding area, in addition to disseminating information to the 
community and areas distant from these services may not receive this benefit. 
Other areas for future research include obtaining more specific information 
about how doctors assess severity of pain, in particular, examining the criteria for 
judging pain as 'severe'. In addition, in the present study GPs indicated they were 
generally satisfied with their resources for pain. control, however the question could 
be extended to determine whether GPs are equally satisfied with their resources for 
pain in non-terminal patients and/or for non-cancer pain. Devising a study which 
compares doctors opinions' about different forms of pain control in palliative care 
with their actual prescribing and referral practices could provide some useful insight 
into 'best' versus 'realistic' practice. 
43 
In theory, it is well recognised that patients in palliative care and their 
families require a time- and resource-intensive approach to give them the type of care 
which supports them adequately through a period of life which is often physically 
and emotionally complex and painful. Unfortunately, at the present time, it seems as 
ifthe structures are not in place to provide more than haphazard 'holistic' care and 
psychologists must be encouraged to campaign actively for greater inclusion of their 
particular expertise in this field. 
Pain is equally a sensation and an emotional reaction to that sensation 
(Merskey & Bogduk, 1994). Morphine only addresses the first, which it does very 
effectively, albeit with undesirable side effects. The results of this study suggest that 
concern for the unmet analgesic needs of cancer patients should not be limited to 
improving access to morphine and similar pharmacology. This leads to the 
prediction that in the medical environments of general practise or palliative care 
wards, greater attention to and provision for patient self efficacy and emotional 
support will affect pain directly and indirectly. It could be productive to investigate 
patient reaction to morphine specifically and pain control generally with and without 
techniques aimed at enhancing these variables. Self efficacy can be bolstered by the 
addition of an increased range of non-pharmacological options to supplement pain 
control, based on patient preference and available expertise and extending beyond the 
options used in this study. Examples could include simple practical techniques, 
psychological techniques, psychodynamic therapy and alternative therapies, with the 
emphasis on choice and family involvement. When these types of interventions are 
routinely added to mainstream medical treatment, patients may ultimately achieve 
better pain control and higher quality of life. 
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Attitudes t<YPainManagement -9--~~ : · Attitudes to Pain Management 
, , 
The following questions relate to ~pinions and ,preferences regarding .the management of pain. 
Please answer them according to your current opinion. Do not spend too much time on any one 
question. 
(1) How many years have you been practising? 
(2) Was your medical training obtained in Australia? 
(If No), which country? 
(3) a) Have you treated patients with cancer? 
b) Have you had any specialist training in palliative care? 
(If Yes) What was that training? 
c) Have you ever worked in a palliative care setting? 
Date: I I 1995 
year(s) 
Yes 0 No 0 [Tick one] 
Yes 0 No 0 [Tickone} 
Yes D No 0 [Tick one] 
Yes 0 No 0 [Tickonej 





Every few months D 
Less often D 
Never D [Tick one] 
(5) In your practice, how often do your patients have pain caused by cancer? [Tick one] 
Always D Frequently D Sometimes D Rarely D NeverD 
IF YOU ANSWERED "NEVER" TO BO'IH QUESTIONS 4 & 5: THANK YOU FOR YOUR 
- CO-OPERATION. 
OTHERWISE. PLEASE CONTINUE ~~ 
II 
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( 6) In a case of pancreatic cancer, what is your first choice analgesic agent for treatment of: 
a) Mild pai1:1? 
b) Moderate pain? 
c) Severe pain? 
(7) Of the following, which factor do you rate as the most important when choosing an analgesic 
for cancer pain? 
Intensity of pain 
Specific aetiology of pain 
Previous experience of analgesic 
Duration of action 










(8) Overall, do you have reservations in prescribing narcotic analgesics? 
YesO No D [Tick one] 
(9) Have you ever used any type of narcotic analgesic, including morphine, in the treatment of a 
cancer patient? 
Yes 0 No 0 [Tick one] 
.(J. .(J. 
I (IF NO) PLEASE GO TO QUESTION27 (IF YES) PLEASE CONTINUE ~~ 
(10) When treating cancer patients, which narcotic analgesic do you prescribe most frequently? 
(11) In what proportion of cancer patients have you prescribed morphine? 
All 0 Most D Some 0 Few D None D [Tick one} 
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(12) In what proportion of non-terminal cancer patients have you prescribed morphine? 
All D Most D Some D Few D None D [Tick one] 
(13) Overall, do you have reservations in prescribing morphine to non-terminal patients? 
YesD No D [Tick one} Comments: 
(14) Generally speaking, what are your criteria for prescribing morphine? 
(15) Does your awareness of the thriving black market in opiates ever influence your decision to 
prescribe morphine? 
YesO No D [Tick one] 
Comment: 





Control of side effects 










(17) What is the greatest difficulty which you have encountered when treating cancer patients? 
[Tick one] 
Family problems 0 
Treatment of pain 0 
Treatment of other J!hysical symptoms 0 
Giving information to client 0 
Other (specify): 0 
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(18) What is the greatest difficulty which you have encountered in the use of morphine in cancer 
patients? [Tick one J 
Administrative difficulties in prescription 
Prescribing dosage 
Knowledge and development of side effects 
Knowledge of longer term use 








(19) Which method of administration do you prescribe most often for morphine? 
Injection D 




Other D (specify): 
[Tick one] 
(20) For terminal cancer patients, do you usually provide pain control at fixed time intervals or on 
demand? [Tick one] 
Fixed intervals D 
On demand D 
Both equally D 
(21) Which of the following side effects do your patients regularly encounter with morphine use? 
[Tick all relevant] 
Constipation D Sedation D 
Nausea D Vomiting D 
Confusion D Hallucinations D 
Nightmares D Urinary Retention D 
Diuiness/Unsteadiness D Respiratory Depression D 
Addiction D Other D 
(please specify): 
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(22) Which of the following aspects of treating pain with morphine in terminal cancer patients are 
you concerned about? [Tick all relevant] 
Tolerance D 
Dependence D 
Impairment of Cognitive Function 0 
Other Side Effects 0 
(23) In your opinion, what is the greatest advantage of using morphine? 
(24) In your opinion, what is the greatest disadvantage of using morphine? 
(25) Do patients or families usually object to the prescription of morphine for pain control? 
[Tick one] 
Never 0 Rarely D Sometimes D Frequently 0 Always D 
(26) What is the most common objection to morphine raised by patients? by their relatives? 
[Tick one in each column] 
Fear of addiction 
Pain not severe enough 
Fear there will be nothing stronger if pain continues/increases 
Familial disapproval 
Fear of dying 
Method of administration 
Concern with side effects 
Cost 





















(27) Have you experienced difficulty with patient compliance when morphine has been prescribed? 
Always 0 Frequently 0 Sometimes D Rarely D NeverD [Tick one] 
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(28) Which do you believe your patients fear more, pain or death? 
Pain D Death D No Difference D [Tick one] 
(29) a) Do you routinely give patients basic information about morphine, when you prescribe it? 
Yes D No 0 [Tickone] 
b) Do you routinely give information about morphine to a patient's relatives or significant 
others, when you prescribe it? 
Yes 0 No D [Tickone] 






Other D (specify): 
(31) a) Do you have experiences of the use of morphine outside your professional life? 
Yes D No D [Tick one] 
(If Yes) b) Were those experiences predominantly 
Po~itive D Neutral D Negative D ? [Tick one] 
(32) How satisfied are you with the pain control you are able to offer your terminally ill cancer 
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(33) a) Are you satisfied with your resources for pain control generally? 
YesD NoD [Tick one] 
(34) Apart from radiation or chemotherapy, do you ever suggest non-pharmaceutical interventions 
to supplement pain control medication? 
YesO NoD [Tick one} 
(If Yes) What are they? [Tick all relevant] 
Relaxation D Active Coping D 
Thought Stopping D Heat& Cold D 
Imagery D TENS Machine D 
Deep Breathing D Positioning D 
Massage D Movement 0 
Distraction D Hypnosis D 
Acupuncture D Naturopathy D 
Laser Therapy D Homeopathy o· 
Music D Art Therapy D 
Other D [specify]: 
(35) In your experience, do any of the non-pharmaceutical interventions listed above significantly 
assist a patient's ability to cope with pain? · 
Yes D No D [Tick one] 
(36) a) Do you refer to health professionals other than oncologists, radiotherapists and palliative 
care specialists for the provision of non-pharmaceutical interventions to supplement pain control 
medication? [Tickone] 
Always D Frequently D , Sometimes D Rarely D NeverO 
b) Which other health professionals do you refer your patients with pain to? 
(Tick all relevant) 
Nurse 0 Art Therapist D 
Psychologist 0 Physiotherapist D 
Counsellor 0 Occupational Therapist D 
Psychiatrist 0 Masseuse D 
Music Therapist 0 Self Help Group D 
Other D (specify): 
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(37) a) Are palliative care services available to patients in your area? 
Yes D No D [Tickone] 
(If Yes) b) Do you regularly refer to them? 
Yes D No D [Tick one J 
(38) a) How often do you involve services other than palliative care in your management of cancer 
pain? [Tick one] 
NeverD Rarely D Sometimes D Frequently 0 · Always D 
b) Which other services do you regularly involve in your management of cancer pain? 
(39) a) Do you regard dealing with terminally ill patients as more difficult than dealing with other 
patients? [Tick one] 
More difficult D Equal D Less difficult D 
(If Yes) b) What specifically do you find difficult? 
( 40) Which of the following professional development topics do you consider would particularly 
benefit your practise? [Tick all relevant] 
Cancer pain management D 
Control of other symptoms D 
Communicating with dying patients 0 
Bereavement counselling D 
Non-pharmaceutical methods of supplementing pain control D 
Access to advice from practitioners experienced in terminal care D 
~~~ D 
03 THANK,YOU FOR YOUR CO-OPERATION &> I 
APPENDIXB 
«Title» «FirstName» «LastName» 
«Address 1 » 
«City» «State» «PostalCode» 
Dear «Title» «LastName», 
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November 29th, 1995 
We are conducting a short survey concerning practices in pain management and current attitudes in 
the medical community in Tasmania. I would like to take this opportunity to ask you to participate 
in this survey, which is being conducted under the auspices of the Hobart Repatriation General 
Hospital and The University of Tasmania. Completing this questionnaire should only take 
approximately ten minutes of your time. Your name and address details have not been requested, so 
please be assured that any information you provide is confidential and will be used only for the 
purpose of gathering information about pain management in general practice. 
If you have any questions or comments to make, please note them here, together with a contact 
name and address and I will be happy to answer the).TI. Alternatively call me on (002) 250 863, 
which has an answering machine. 
If you are willing to participate, please complete and return the questionnaire in the reply paid 
envelope provided, as soon as possible. Otherwise, please decline below and return these papers in 
the same envelope. 
Thank you for your time. 
Caroline Long 
Master of Psychology (Clinical) Student 
I DO 0 DO NOT 0 wish to participate in this survey. (Tick .one) 
Please Note: Infoma.tion about the 1'esults of this survey will be sent to all Tasmani41i Divisibns 
of General Practice. 'If y()u wquld like forlhet i11formatio1t, please contact the researcher at the , 
above number. 
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December 5th, 1995 
Dear Doctor, 
A week ago you received a letter asking you to complete an accompanying ten minute questionnaire 
concerning the use of and attitudes towards pain management in the medical community in 
Tasmania. 
• If you have replied to this request, thank you for your trouble. Please disregard this letter. 
• If you have not yet completed EITHER the questionnaire OR the refusal, please do so, as soon 
as possible. I am sure you appreciate that good research requires a respectable response rate. 
Your name and address details have not been requested, so please be assured that any information 
you provide is confidential and will be used only for the purpose of gathering information about 
pain management in general practice. This survey is being conducted under the auspices of the 
Hobart Repatriation General Hospital and The University of Tasmania. 
If you do not wish to participate, please indicate this below and return the papers in the self 
addressed envelope provided. If you require a replacement copy of the questionnaire, please call me 
on (002) 25-0863 or write as soon as possible, providing your name and a contact address. 
Yours sincerely, 
Caroline Long 
Master of Psychology (Clinical) Student 
I DO LI DO NOT Cl wish to participate in this survey. (Tick one) 
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PATIENT: 









Has (s)he ever taken morphine? 




Prim a ry Diagnosis: 
Yes 0 No 0 
Yes 0 No D 
Yes D No D 
Date: I /95 
Medication presently used: _____________________ _ 
(1) Are you feeling any pain right now? Yes D No D 
(If Yes) a) On a scale of one to five, with five being the strongest pain you would imagine 
and one being a mild twinge, how would you rate your current pain? __ _ 
b) How long have you been feeling this pain? mthsD daysO hrsO minsD 
(If No) Have you had any pain with this illness? Yes D No 0 
(2) How long ago did you first learn of your illness? _______ _ 
(3) Are you satisfied with the medication you are taking? Yes 0 No 0 
(If No) What don't you like about it? _______________ _ 
(4) Do you think your medication gives you any side effects? Yes 0 No 0 
(If Yes) What side-effects have you noticed? Constipation 0 Sedation 0 Nausea 0 
Vomiting 0 Confusion 0 Hallucinations 0 Nightmares 0 Urinary retention D 
Diuiness D Addiction D Unsteadiness 0 Dependence D Other: _____ _ 
(5) What side-effects cause the greatest problems for you? ____________ _ 
(6) Are you taking morphine/MS Contin/(morphine brand names)? Yes 0 No 0 
(If Yes) How long have you been taking it? daysO wksO mthsD yrsD 
(If No) Has your doctor ever suggested you take morphine? Yes 0 No 0 
(I/Yes- GO TO Qn 8 ~~) 
(I/No- Go to Qn 17 ~~) 
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(7) How do you usually take morphine? Injection D Syringe driver D Tablet D 
Solution D Suppository D Other O: ________ _ 
(8) What was your reaction, when it was first suggested that you take morphine? 
(9) Have you or your family ever been worried about you taking morphine? Yes D No D 
(If Yes) What were you worried about? _________________ _ 
(10) Have you ever been worried about becoming addicted to morphine? Yes D No D 
(11) How do you feel about morphine now?------------------
(12) Have you had any previous experiences with morphine? 
(If Yes) Were those experiences mainly good D, 
Yes D No D 
bad D OR neutral D? 
(13) Has anyone you know ever used morphine? Yes D No D 
(If Yes), did it work well? Yes D No D 
(14) Did the medical staff give you any information about morphine? Yes D No D 
(If Yes) What information were you given about morphine?-----------
(If Yes) Who gave it to you?---------------------
(15) Was the information volunteered, or did you ask? volunteered D asked D 
(16) Were all your questions about morphine answered to your satisfaction? Yes D No D 
(17) Would you consider your pain is under control? Yes D No D 
(18) Do you get pain relief when you ask for it, or at specific times of the day? 
when I ask D regular interals D both D 
(19) Have you been taking your medication regularly? Yes D No D 
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(20) Do you think you need more or less medication than you are currently receiving? 
More 0 Less 0 SameO 
(21) Is there anything about your medication you would change, if you could, either now, or in the 
past? Yes D No D 
(If Yes) What would you change? __________________ _ 
(22) What is the greatest difficulty which you have encountered while being ill?: (prompt card) 
Family problems D Treatment of pain D 
Getting information from medical staff D 
Treatment of other physical symptoms 0 
Other [specify}: 0 
(23) Have any of the medical staff ever suggested non-drug ways of helping you to control pain? 
Yes 0 No 0 
(If Yes) What were they? Relaxation D Thought stopping D 
Deep breathing 0 Massage D Distraction D 
Heat& Cold D Hypnosis D TENS machine D 
Movement D Music D Naturopathy D 
Art Therapy D Homeopathy D Acupuncture D 
(24) Have you ever tried other ways of dealing with pain? 
(If Yes) What were they? 
(prompt card) 
Imagery 0 
Active coping D 
Positioning D 
Laser Therapy D 
Other 0 
(specify): 
Yes 0 No D 
(25) Do you think techniques such as relaxation, music, deep breathing, hypnosis, would help you 
to control your pain better? Yes 0 No D 
(26) Do you have any questions you want to ask me? ____________ _ 
Would you like me to leave my card with you, in case you have questions later on? 
Yes 0 No D 
ffiANK YOU FOR YOUR TIME. 
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Is patient taking morphine? 
If No) Has (s)he ever taken morphine? 




BD Subject Number: 
---
Patient's First Name:-----------------
Carer's Relationship to Patient: --------------
(1) Is (patient's name) feeling any pain right now? YesO NoO 
YesO NoO 
YesO No 0 
YesO No 0 
Date: I 195 
Don't Know D 
(If Yes) a) On a scale of one to five, with five being the strongest pain you would imagine 
and one being a mild twinge, how would you rate (patient's name) current pain? __ _ 
b) How long has (s)he been feeling this pain? mthsD daysO hrsD minsD 
(If No) Has (patient's name) had any pain with this illness? Yes 0 No 0 
(2) How long ago did you first learn of (patient's name)'s illness? _______ _ 
(3) Are you satisfied with the medication (patient's name) is taking? Yes 0 NoD 
(If No) What don't you like about it?-----------------
(4) Do you think the medication gives (patient's name) any side effects? Yes D No D 
(If Yes) What side-effects have you noticed? Constipation D Sedation 0 Nausea 0 
Vomiting 0 Confusion D Hallucinations 0 Nightmares D Urinary retention D 
Dizziness D Addiction D Unsteadiness D Dependence D Other: _____ _ 
( 5) In your opinion, what side-effects cause the greatest problems for (patient's name)? 
(6) Is (patient's name) taking morphine/MS Contin/(morphine brand names)? Yes D No D 
(If Yes) How long has (s)he been taking it? daysO wksO mths0 yrsD 
(If No) Has (patient's name)'s doctor ever suggested (s)he take morphine? 
Yes D (If Yes - GO TO Qn 8 ~~) 
No D (lfNo- GOTOQn17 ~~) 
Don'tKnow D 
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(7) How does (s)he usually take it? 
Injection D Syringe driver D Tablet 0 Solution D Suppository D 
Other D: ________ _ 
(8) What was your reaction, when it was first suggested that (patient's name) takes morphine? 
(9) Have you or (patient's name) ever been worried about him/her taking morphine? 
Yes D No 0 
(If Yes) What were you worried about?------------------
(I 0) Have you ever been worried about (patient's name) becoming addicted to morphine? 
YesO NoO 
(11) How do you feel about morphine now?------------------
(12) Have ~had any previous experiences with morphine? YesO NoO 
(If Yes) Were those experiences mainly good0 bad D OR neutral 0 ? 
(13) Apart from (patient's name), has anyone you know ever used morphine? Yes 0 No D 
(If Yes), Did it work well? YesO NoD 
(14) Did the medical staff give you any information about morphine? YesO NoD 
(If Yes) What information were you given about morphine?-----------
(If Yes) Who gave it to you? ____________________ _ 
(15) Was the information volunteered, or did you ask? volunteered 0 asked 0 
(16) Were all your questions about morphine answered to your satisfaction? Yes 0 No D 
(17) Would you consider (patient's name)'s pain is under control? Yes 0 No 0 
(18) Has (patient's name) been taking his/her medication regularly?YesO NoD Don't Know 0 
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(19) Do you think (patient's name) needs more or less medication than (s)he is currently receiving? 
More D Less 0 Same D 
(20) Is there anything about (patient's name)'s medication you would change, if you could, either 
now, or in the past? 
YesO .NoO 
(If Yes) What would you change? __________________ _ 
(21) What is the greatest difficulty which you have encountered with (patient's name) being ill?: 
(prompt card) 
Family problems 0 Treatment of pain D Treatment of other physical symptoms D 
Getting information from medical staff D Other [specify}: D 
(22) Have any of the medical staff ever suggested non-drug ways of helping (patient's name) to 
control pain? Yes 0 No D Don'tKnow D (prompt card) 
(If Yes) What were they? Relaxation D Thought stopping D Imagery D 
Deep breathing 0 Massage D Distraction D Active coping D 
Heat& Cold D Hypnosis D TENS machine D Positioning D 
Movement D Music D Naturopathy D Art Therapy D 
Laser Therapy D Homeopathy D Acupuncture D Other D 
(specify): 
(23) Has (patient's name) ever tried other ways of dealing with pain? Yes D No D 
(If Yes) What were they? 
(24) Do you think techniques such as relaxation, music, deep breathing and hypnosis would help 
(patient's name) to control his/her pain better? Yes D No D 
(25) Do you have any questions you want to ask me?--------------
Would you like me to leave my card with you, in case you have questions later on? 
Yes D No D 
THANK YOU FOR YOUR TIME. 
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1) Family problems 
2) Treatment of pain 
3) Treatment of other physical symptoms 
4) Getting in/ ormation from medical staff 
5) Other 
1) Relaxation 
2) Thought stopping 
3) Imagery 
4) Deep breathing 
5) Massage 
6) Distraction 
7) Active coping 
8) Heat & Cold 
9) TENS machine 
10) Positioning 
Appendix F 75 






16) Laser Therapy 
17) Music 
18) Art Therapy 
19) Other 
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Attitudes to pain management with morphine in palliative care. 
Chief Investigator: Dr Alison Garton 
We would like to take the opportunity to invite you to participate in research about 
people's opinions on pain control, in particular, morphine. This study is being conducted 
by Caroline Long as part of a Master's thesis. It is being done to provide better 
information about the general effectiveness and value of morphine and to help improve 
knowledge about the best way to use it. We are interested in interviewing patients 
with cancer who have been prescribed morphine at some stage in their illness, 
and their nominated significant others. You do not need to be taking morphine at 
this time to be included. We are asking you to complete an interview with the researcher, 
answering questions relating to your personal experience of pain control. This should 
only take about fifteen minutes. We will then ask you to choose someone close to you, 
to answer similar questions. We will not be asking for anything further. 
All the information you give is confidential. Every effort will be made to maintain 
confidentiality of research data and only researchers will have access to any identifying 
data. The only personal information required from you, is your first name. 
This interview is not compulsory and you can stop at any time. If you decide not to 
answer any questions, this will have no effect on your treatment in hospital or at home, 
either now or in the future. If you are not feeling well enough, this interview can occur 
later It is possible that talking about medication and pain control could make you feel 
uncomfortable or distressed. If you are not sure about the interview, you can answer just 
one or two questions and decide whether you wish to continue. 
If you have any questions or concerns about this interview, you can contact the 
researcher, Caroline Long (ph: 25-0863) for more information. If you have concerns 
of an ethical nature or complaints about the manner in which this research is conducted, 
you may contact the following people: 
Chair of the Ethics Committee - Dr Paul Mccann 
Acting Chair (from 1/10/95) - Dr Rosalie Parton 
Secretary of the Ethics Committee - Ms Chris Hooper 
ph: 38-8255 
ph: 38-8255 
ph: 38-8160 or 20-2763 
This research has received ethical approval from the Acute Care Program Ethics 
Committee and complies with the laws of the State. You will be given copies of this 
information sheet and the consent form for your own records. 
If you are willing to be interviewed, please call Caroline Long on 25-0863 
between the hours of 9-5 to make an appointment. This number has an answering 
machine for times when the telephone is unattended. Alternatively, please tell your 
Palliative Care Team member if you are willing to be involved and Caroline will call 
you to make an appointment. 
Involvement in this research only requires one interview from you and one from the person 
you nominate. The interviews will be conducted in your home, at your convenience. 
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Consent Form: 
Attitudes to pain management with morphine in palliative care. 
I have read and understood the 'Information Sheet' for this study. I understand that the purpose 
of this interview is to gather information about opinions on pain control. The nature and 
possible effects of the study have been explained to me. I understand that I am only being 
asked to answer questions relating to my /patient's personal experience of illness. 
I have been told that all the information I may offer will be kept confidential and the only 
personal information required is my first name. I have been informed that the results of the 
study may not be of any direct benefit to my medical management. I also understand that this 
interview is not compulsory and I can stop at any time. If I decide not to answer any questions, 
this will have no effect on my treatment in hospital, either now or in the future. 
I have read the information above and any questions I have asked have been answered to my 
satisfaction. I agree to participate in this investigation and understand that I may withdraw at 
any time without penalty. 
Name: 
Address: 
I agree that research data gathered for the study may be published provided that I cannot be 
identified as a subject. 
Name of subject 
Signature of subject 
Date 
Name of witness 
Signature of witness 
Date 
I have explained this study and the implications of participation in it to this volunteer and I 
believe that the consent is informed and that he/she understands the implications of 
participation. 
Name of researcher Caroline Long 
Signature of researcher 
Date 
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Dear 
During his stay on Whittle Ward, your agreed to be interviewed 
for his opinions about ~s pain management, which is part of some research we are 
conducting on the ward. As part of that interview, we asked him to choose the person 
closest to him, to answer some similar questions in a short interview and he chose 
you. He has an information sheet describing what the interview is about. It will give 
you a clearer idea of what we are doing. 
We would like to get in contact with you to do this short interview, if you are willing. 
As with 's interview, this is not compulsory and you may stop th~. 
interview at any time. If you decide not to answer any questions, this will have no 
effect on his stay in hospital or future treatment. All the information you give is 
confidential. 
If you are willing to be involved, please call Caroline Long on 25-0863 (bh) to 
arrange a time to come to Whittle Ward for this short interview. This telephone 
number has an answering machine for times when the telephone is unattended. 
Alternatively, you can leave your name and a contact number with the Whittle Ward 
receptionist, Ann, and Caroline will call you. Interviews can be arranged to fit in with 
what is convenient for you and can occur on weekends or weekdays. If you choose 
not to be interviewed, could you leave a message on the above number, or with Ann, 
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For a short time in December and again in January, patients and families are going to be 
interviewed on Whittle Ward. 
• My name is Caroline Long and I am completing a Master's degree in Psychology. 
• I am exploring people's reactions to and beliefs about morphine in palliative care. 
• I am interested in interviewing cancer patients who are using or have used morphine. 
• I will be asking each patient I interview to identify someone close to them for me to interview. 
• Each interview should only take approximately 15 minutes, plus a short time to explain the 
interviews and obtain informed consent. If a patient wants or needs to stop the interview, they 
can stop at any time. The interviews will take a back seat to any hospital care. 
• The interviews ask about the patient's experience of pain, medication. They contain nothing 
overtly distressing or personal. All information given is confidential. 
• All interviews will be completed by me. I am a qualified psychologist with clinical experience. 
• I will ask each person I interview to sign a consent form beforehand. If they are not capable of 
giving informed consent then I can not interview them. 
• Each day when I come in to interview patients I will ask the nursing staff to identify which 
patients are well enough for me to approach. 
• I will also be asking nursing staff to inform me if a patient has any comments or queries 
about the interviews, or if they appear to be in any way uncomfortable as a result of the 
interview. 
• Any feedback nursing staff have about these interviews, any of the procedures, or any perceived 
effects they have on the patients, would be welcome. 
• Interviews will be sought during the daytime on Tuesdays, Thursdays, and on the weekends. I 
will also be available after 5pm any other day of the week. Given it will be difficult to catch 
family members, I will be leaving each patient I interview with a letter asking their nominated 
family member to contact me for an interview, which they can refuse if they prefer. 
• Dr Alison Garton from the Department of Psychology (University of Tasmania) is the Chief 
Investigator for this research, which has been approved by the Acute Care Program Research and 
Ethics Committees and the University of Tasmania. Dr Paul Dunne has been consulted 
throughout. Dr Christine Clifford is also acting as a supervisor. 
• When this research is completed, the results will be summarised and made available to the 
hospital, particularly Whittle Ward. 
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Table 11 
Associations between GPs who reported they had specialist training in palliative <?are 
(yes/no) and their choice of professional development topics (beneficial/not beneficial) 
(N=232). 
Professional Specialist Beneficial to Not beneficial to x2 2-tailed 
development topic Training practise practise significance 
N % N % 
Cancer Pain Yes 12 5.2 17 7.3 .55 n.s. 
Management No 99 42.7 104 44.8 
Control of Other Yes 19 8.2 10 4.3 2.5 n.s. 
Symptoms No 101 43.5 102 44.0 
Communicating with Yes 11 4.7 18 7.8 .12 n.s. 
Dying patients No 84 36.2 119 51.3 
Bereavement Yes 13 5.6 16 6.9 .00 n.s. 
Counselling No 92 39.7 111 47.8 
Non-Pharmacological 
Methods of Yes 17 7.3 12 5.2 .36 n.s. 
Supplementing Pain No 107 46.1 96 41.4 
Control 
Access to Advice Yes 10 4.3 19 8.2 .57 n.s. 
from Practitioners No 85 36.6 118 50.9 
Experienced 
in Palliative Care 
None of these Yes 2 .9 27 11.6 .25 n.s. 
No 27 11.6 183 78.9 
* p <.OS 
